var title_f21_52_22336="Contents: Genitourinary cancer";
var content_f21_52_22336=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?3/43/3774\">",
"       Oncology",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Genitourinary cancer",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Genitourinary cancer",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Bladder cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/4/29766\">",
"           Adjuvant chemotherapy for muscle invasive urothelial (transitional cell) carcinoma of the bladder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/34/35367\">",
"           Chemoprevention of bladder cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/47/20217\">",
"           Clinical presentation, diagnosis, and staging of bladder cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/23/31096\">",
"           Complications of intravesical BCG immunotherapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/61/26586\">",
"           Epidemiology and etiology of urothelial (transitional cell) carcinoma of the bladder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?28/47/29431\">",
"           Experimental systemic therapy of metastatic bladder cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/39/5749\">",
"           Laparoscopic/robotic-assisted radical cystectomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/45/1754\">",
"           Malignancies of the renal pelvis and ureter",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/0/41992\">",
"           Neoadjuvant treatment and bladder preservation options for muscle-invasive urothelial (transitional cell) bladder cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/29/40409\">",
"           Nonurothelial bladder cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/44/2759\">",
"           Overview of the management of urothelial (transitional cell) bladder cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/53/27481\">",
"           Pathology of bladder neoplasms",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/39/634\">",
"           Radical cystectomy and bladder-sparing treatments for urothelial (transitional cell) bladder cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/33/22039\">",
"           Screening for bladder cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/6/11366\">",
"           Small cell carcinoma of the bladder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/27/19897\">",
"           Treatment of metastatic urothelial cancer of the bladder and urinary tract",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/11/40122\">",
"           Treatment of non-muscle-invasive bladder cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/34/32298\">",
"           Urinary diversion and reconstruction following cystectomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/6/40041\">",
"           Urine biomarkers for the detection of urothelial (transitional cell) carcinoma of the bladder",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Female genital tract malignancy",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/32/35337\">",
"           Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/15/40185\">",
"           Cervical cytology: Interpretation of results",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/6/31849\">",
"           Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Clinical features and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/23/25978\">",
"           Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Epidemiology and risk factors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/48/36618\">",
"           Epithelial ovarian cancer: Initial surgical management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/52/17224\">",
"           Epithelial ovarian cancer: Pathology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/15/25847\">",
"           Epithelial ovarian cancer: Second look surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/11/21689\">",
"           First-line chemotherapy for advanced (stage III or IV) epithelial ovarian, fallopian tubal, and peritoneal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/11/24761\">",
"           Gestational trophoblastic disease: Epidemiology, clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/30/23015\">",
"           Gestational trophoblastic disease: Management of hydatidiform mole",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/31/13816\">",
"           Gestational trophoblastic disease: Pathology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/15/42234\">",
"           Gestational trophoblastic neoplasia: Staging and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/17/29977\">",
"           Medical treatment for relapsed epithelial ovarian, fallopian tubal, or peritoneal cancer: Platinum-resistant disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/21/37209\">",
"           Medical treatment for relapsed epithelial ovarian, fallopian tubal, or peritoneal cancer: Platinum-sensitive disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/57/24472\">",
"           Neoadjuvant chemotherapy for newly diagnosed advanced ovarian cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/37/5721\">",
"           Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/31/5624\">",
"           Overview of epithelial carcinoma of the ovary, fallopian tube, and peritoneum",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/45/16087\">",
"           Overview of sex cord-stromal tumors of the ovary",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?18/14/18665\">",
"           Preinvasive and invasive cervical neoplasia in HIV-infected women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/14/10474\">",
"           Screening for ovarian cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?8/36/8778\">",
"           Sex cord-stromal tumors of the ovary: Granulosa-stromal cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/30/13799\">",
"           Struma ovarii",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/24/33162\">",
"           Treatment of malignant germ cell tumors of the ovary",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/22/2408\">",
"           Uterine sarcoma: Classification, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/30/31208\">",
"           Vaginal cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/27/5560\">",
"           Vaginal intraepithelial neoplasia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/5/9303\">",
"           Vulvar cancer: Clinical manifestations, diagnosis, and pathology",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/11/32952\">",
"           Vulvar intraepithelial neoplasia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Other renal malignancies",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?42/18/43303\">",
"           Renal manifestations of tuberous sclerosis and renal angiomyolipoma",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Penile cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/21/42328\">",
"           Carcinoma of the penis: Clinical presentation and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/13/26840\">",
"           Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/4/41033\">",
"           Carcinoma of the penis: Surgical and medical treatment",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Prostate cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/41/41622\">",
"           Bone metastases in advanced prostate cancer: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/48/41736\">",
"           Chemoprevention strategies in prostate cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/8/6280\">",
"           Chemotherapy in castrate-resistant prostate cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/29/25049\">",
"           Clinical features, diagnosis, and treatment of radiation proctitis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/16/36101\">",
"           Clinical presentation and diagnosis of prostate cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/63/43000\">",
"           Cryotherapy and other ablative techniques for the initial treatment of prostate cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/47/23290\">",
"           External beam radiation therapy for localized prostate cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?16/36/16969\">",
"           Initial approach to low-risk clinically localized prostate cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/20/1353\">",
"           Initial hormone therapy for metastatic prostate cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/26/21930\">",
"           Initial management of regionally localized intermediate and high risk prostate cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/62/23527\">",
"           Initial staging and evaluation of men with newly diagnosed prostate cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/8/36999\">",
"           Management of bone metastases in advanced prostate cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/2/41001\">",
"           Measurement of prostate specific antigen",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/55/38770\">",
"           Patient information: Prostate cancer screening (Beyond the Basics)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/30/9704\">",
"           Prostate cancer: Risk stratification, other prognostic factors, and predictive tools",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/47/24313\">",
"           Radical prostatectomy for localized prostate cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/48/33544\">",
"           Rising serum PSA following local therapy for prostate cancer: Definition, natural history, and risk stratification",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/52/31562\">",
"           Risk factors for prostate cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/39/38520\">",
"           Secondary endocrine therapies for castration resistant prostate cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Renal cell carcinoma",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/32/28170\">",
"           Anti-angiogenic and molecularly targeted therapy for advanced renal cell carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/5/22618\">",
"           Clinical features, diagnosis, and management of von Hippel-Lindau disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/32/35336\">",
"           Clinical manifestations, evaluation, and staging of renal cell carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/9/2200\">",
"           Diagnostic approach, differential diagnosis, and treatment of a small renal mass",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/52/18250\">",
"           Epidemiology, pathology, and pathogenesis of renal cell carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/4/35910\">",
"           Hereditary kidney cancer syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/14/12522\">",
"           Immunotherapy of renal cell carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?14/21/14678\">",
"           Molecular biology and pathogenesis of von Hippel-Lindau disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/1/21528\">",
"           Overview of the treatment of renal cell carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/44/21192\">",
"           Prognostic factors in patients with renal cell carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/44/26310\">",
"           Radiofrequency ablation and cryoablation for renal cell carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/6/22630\">",
"           Role of surgery in patients with metastatic renal cell carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/26/5546\">",
"           Surgical management of localized renal cell carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/38/32360\">",
"           Surveillance for metastatic disease after nephrectomy for renal cell carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/63/1012\">",
"           Urinary tract malignancy and atherosclerotic disease in patients with chronic analgesic abuse",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Renal pelvis tumors",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/63/1012\">",
"           Urinary tract malignancy and atherosclerotic disease in patients with chronic analgesic abuse",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Testicular cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/16/3334\">",
"           Active surveillance following orchiectomy for stage I testicular germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/40/5770\">",
"           Anatomy and pathology of testicular tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/47/41720\">",
"           Clinical manifestations, diagnosis, and staging of testicular germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/24/13706\">",
"           Effects of cytotoxic agents on gonadal function in adult men",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/25/2457\">",
"           Epidemiology of and risk factors for testicular germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/52/10058\">",
"           Extragonadal germ cell tumors involving the mediastinum and retroperitoneum",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/63/24568\">",
"           Initial risk-stratified treatment for advanced testicular germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/29/26070\">",
"           Management of stage I nonseminomatous germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/19/10550\">",
"           Management of stage II nonseminomatous germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/7/13432\">",
"           Overview of the treatment of testicular germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/25/30105\">",
"           Pediatric intracranial germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/45/9943\">",
"           Posttreatment follow-up for men with testicular germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/63/33782\">",
"           Radical inguinal orchiectomy for testicular germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?9/3/9272\">",
"           Retroperitoneal lymph node dissection in testicular germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/17/24852\">",
"           Risk stratification of metastatic testicular germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/58/38822\">",
"           Serum tumor markers in testicular germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/33/38425\">",
"           Surgical management of advanced testicular germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/27/42425\">",
"           Testicular intratubular germ cell neoplasia, unclassified (testicular carcinoma in situ, testicular intraepithelial neoplasia)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?6/40/6789\">",
"           Testicular sex cord stromal tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/56/2954\">",
"           Treatment of relapsed and refractory testicular germ cell tumors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?22/2/22567\">",
"           Treatment of stage I seminoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/45/22230\">",
"           Treatment of stage II seminoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/49/20250\">",
"           Treatment-related toxicity in men with testicular germ cell tumors",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Urethral cancer",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?10/26/10664\">",
"           Urethral cancer in men",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/35/34357\">",
"           Urethral cancer in women",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-BF0F0D85BF-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f21_52_22336=[""].join("\n");
var outline_f21_52_22336=null;
var title_f21_52_22337="Pathogenesis pseudomonas in CF";
var content_f21_52_22337=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F51872&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F51872&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 525px\">",
"   <div class=\"ttl\">",
"    Schematic model of the pathogenic events hypothesized to lead to chronic P. aeruginosa infection in airways of CF patients",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 505px; height: 302px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) On normal airway epithelia, a thin mucus layer resides atop the periciliary liquid layer (PCL),&nbsp;shown as clear. The presence of the low-viscosity PCL facilitates efficient mucociliary clearance (denoted by vector). A normal rate of epithelial O",
"    <sub>",
"     2",
"    </sub>",
"    consumption (Q",
"    <sub>",
"     O2",
"    </sub>",
"    ; left) produces no O",
"    <sub>",
"     2",
"    </sub>",
"    gradients within this thin airway surface liquid (ASL) (denoted by bar). (B-F) CF airway epithelia. (B) Excessive CF volume depletion (denoted by vertical arrows) removes the PCL, mucus becomes adherent to epithelial surfaces, and mucus transport slows/stops (bidirectional vector). The raised O",
"    <sub>",
"     2",
"    </sub>",
"    consumption (left) associated with accelerated CF ion transport does not generate gradients in thin films of ASL. (C) Persistent mucus hypersecretion (denoted as mucus secretory gland/goblet cell units) with time increases the height of luminal mucus massages/plugs. The raised CF epithelial Q",
"    <sub>",
"     O2",
"    </sub>",
"    generates steep hypoxic gradients in thickened mucus masses. (D) P. aeruginosa bacteria deposited on mucus surfaces penetrate actively and/or passively (due to mucus turbulence) into hypoxic zones within the mucus masses. (E) P. aeruginosa adapts to hypoxic niches within mucus masses with increased alginate formation and the creation of macrocolonies. (F) Macrocolonies resist secondary defenses, including neutrophils, setting the stage for chronic infection. The presence of increased macrocolony density and, to a lesser extent neutrophils, render the now mucopurulent mass hypoxic.",
"    <div class=\"footnotes\">",
"     NL: normal; CF: cystic fibrosis.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Worlitzsch, D, Tarran, R, Ulrich, M, et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 2002; 109:317. Copyright &copy; 2002 Copyright Clearance Center.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_52_22337=[""].join("\n");
var outline_f21_52_22337=null;
var title_f21_52_22338="Patient information: Blood donation (giving blood) (The Basics)";
var content_f21_52_22338=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"12\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?18/53/19281\">",
"         Patient information: Anemia caused by low iron (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?21/25/21907\">",
"         Patient information: HIV/AIDS (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?25/41/26258\">",
"         Patient information: Hepatitis B (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?31/39/32370\">",
"         Patient information: Hepatitis C (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?29/49/30484\">",
"         Patient information: Anemia caused by low iron (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?26/12/26820\">",
"         Patient information: Blood donation and transfusion (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Blood donation (giving blood) (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/blood-donation-giving-blood-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H16276802\">",
"      <span class=\"h1\">",
"       What is blood donation?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Blood donation is the term doctors use when a person gives (donates) blood. A person who donates blood is called a blood donor. People do not get paid for giving blood. People who give blood do it because they want to. &nbsp;",
"     </p>",
"     <p>",
"      When a person gives blood, his or her blood goes to a &ldquo;blood bank.&rdquo; There it is tested, made ready for use, and stored until it is needed. Hospitals can get blood from a blood bank to give to patients who need it. When a person gets donated blood, it is called a &ldquo;blood transfusion.&rdquo;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16276809\">",
"      <span class=\"h1\">",
"       Who might need donated blood?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People might need donated blood if they:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Lose a lot of blood in an accident or during surgery",
"       </li>",
"       <li>",
"        Have a medical condition that affects their blood",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some people have their own blood drawn and stored if they are planning to have surgery soon. That way, if they need blood during surgery, they can get their own blood.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16276816\">",
"      <span class=\"h1\">",
"       Who can give blood?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People can give blood at age 17 or older. (Some states let people give blood at age 16.)",
"     </p>",
"     <p>",
"      People who want to give blood also need to be healthy and meet certain conditions. Meeting these conditions is important, because it helps to make sure that a donor is healthy enough to give blood. It also helps doctors make sure that the person getting the blood won&rsquo;t get an infection from the donated blood.",
"     </p>",
"     <p>",
"      Some people want to give blood because they know their blood will be tested, and they want to know if they have certain infections, such as HIV. People who want to give blood for this reason aren&rsquo;t allowed to give blood.",
"     </p>",
"     <p>",
"      To check that you meet all of the conditions for giving blood, a doctor, nurse, or trained staff person will ask you questions and do an exam beforehand.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16276823\">",
"      <span class=\"h1\">",
"       What questions will I be asked before I give blood?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A staff person will ask you questions about:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Medical conditions you have or had, including past surgeries",
"       </li>",
"       <li>",
"        Any recent vaccines that you have gotten",
"       </li>",
"       <li>",
"        How you feel that day &mdash; You can&rsquo;t give blood if you don&rsquo;t feel well, have a fever, or are taking certain medicines.",
"       </li>",
"       <li>",
"        Countries you have lived in or traveled to",
"       </li>",
"       <li>",
"        Sex partners you have had &mdash; Men who have had sex with men (even once) since 1977 can&rsquo;t give blood.",
"       </li>",
"       <li>",
"        Any tattoos or body piercings you have",
"       </li>",
"       <li>",
"        Any drug use",
"       </li>",
"       <li>",
"        Your weight &mdash; People who weigh less than 110 pounds (50 kg) are usually not allowed to give blood.",
"       </li>",
"       <li>",
"        Your last blood donation &mdash; People can&rsquo;t give blood too often.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16276830\">",
"      <span class=\"h1\">",
"       What will the exam be like?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The staff person will do a quick exam and check your temperature, blood pressure, and pulse (heartbeat).",
"     </p>",
"     <p>",
"      He or she will also take a small amount of blood from your fingertip to make sure that you do not have a condition called anemia. People with anemia can feel tired or weak, because their body does not have enough red blood cells to carry oxygen. If you have anemia, you can&rsquo;t give blood.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16276837\">",
"      <span class=\"h1\">",
"       What happens when I give blood?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You will sit or lie back in a comfortable chair. The staff person will put a needle in your arm. The needle will stay in place while blood is collected from your arm. Giving blood takes about 15 minutes or less.",
"     </p>",
"     <p>",
"      After you give blood, another staff person will give you some snacks and drinks. He or she will also watch you for a short time to make sure that you don&rsquo;t have any side effects.",
"     </p>",
"     <p>",
"      Before you leave, the staff person will give you a phone number to call in case you have any problems or questions.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16276844\">",
"      <span class=\"h1\">",
"       What side effects can I have from giving blood?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The most common side effects include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Getting a bruise or feeling sore where the needle went in the skin",
"       </li>",
"       <li>",
"        Feeling tired afterward",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Some people can feel faint or pass out. This is more likely to happen if it is your first time giving blood or if you are young or very light. To help prevent feeling faint or passing out, drink a big bottle of water before you give blood.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16276851\">",
"      <span class=\"h1\">",
"       Will my donated blood be tested for problems?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. All donated blood is tested for certain infections that people can catch from infected blood. Some of these infections include HIV, hepatitis B, hepatitis C, West Nile virus, and syphilis.",
"     </p>",
"     <p>",
"      If your blood has any of these infections, the blood bank will let you know. They will also safely get rid of your blood so that it cannot infect anyone else.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16276858\">",
"      <span class=\"h1\">",
"       What if I get sick after I give blood?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you get sick within a few days of giving blood, call the number the staff person gave you. Depending on your symptoms, the blood bank might throw out your blood so that it doesn&rsquo;t infect anyone else.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H16276865\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/53/19281?source=see_link\">",
"       Patient information: Anemia caused by low iron (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?21/25/21907?source=see_link\">",
"       Patient information: HIV/AIDS (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?25/41/26258?source=see_link\">",
"       Patient information: Hepatitis B (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/39/32370?source=see_link\">",
"       Patient information: Hepatitis C (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?26/12/26820?source=see_link\">",
"       Patient information: Blood donation and transfusion (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?29/49/30484?source=see_link\">",
"       Patient information: Anemia caused by low iron (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?21/52/22338?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15874 Version 3.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-40244E071D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_52_22338=[""].join("\n");
var outline_f21_52_22338=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16276802\">",
"      What is blood donation?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16276809\">",
"      Who might need donated blood?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16276816\">",
"      Who can give blood?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16276823\">",
"      What questions will I be asked before I give blood?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16276830\">",
"      What will the exam be like?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16276837\">",
"      What happens when I give blood?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16276844\">",
"      What side effects can I have from giving blood?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16276851\">",
"      Will my donated blood be tested for problems?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16276858\">",
"      What if I get sick after I give blood?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16276865\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?29/49/30484?source=related_link\">",
"      Patient information: Anemia caused by low iron (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/53/19281?source=related_link\">",
"      Patient information: Anemia caused by low iron (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?26/12/26820?source=related_link\">",
"      Patient information: Blood donation and transfusion (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/25/21907?source=related_link\">",
"      Patient information: HIV/AIDS (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?25/41/26258?source=related_link\">",
"      Patient information: Hepatitis B (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/39/32370?source=related_link\">",
"      Patient information: Hepatitis C (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_52_22339="Travoprost: Drug information";
var content_f21_52_22339=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Travoprost: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?10/30/10724?source=see_link\">",
"    see \"Travoprost: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F230214\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Travatan Z&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F230215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Travatan Z&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F230234\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Ophthalmic Agent, Antiglaucoma;",
"     </li>",
"     <li>",
"      Prostaglandin, Ophthalmic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F230217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Glaucoma (open angle) or ocular hypertension:",
"     </b>",
"     Ophthalmic: Instill 1 drop into affected eye(s) once daily in the evening; do not exceed once-daily dosing (may decrease IOP-lowering effect). If used with other topical ophthalmic agents, separate administration by at least 5 minutes.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F230218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F230196\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, ophthalmic [drops]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Travatan Z&reg;: 0.004% (2.5 mL, 5 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F230184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F230199\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be used with other eye drops to lower intraocular pressure. If using more than one ophthalmic product, wait at least 5 minutes in between application of each medication.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F230197\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of the other IOP-lowering medications or insufficiently responsive (failed to achieve target IOP determined after multiple measurements over time) to another IOP-lowering medication",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F230240\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Travatan&reg; may be confused with Xalatan&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F230232\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%: Ocular: Hyperemia (30% to 50%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Angina pectoris (1% to 5%), bradycardia (1% to 5%), hyper-/hypotension (1% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Anxiety (1% to 5%), depression (1% to 5%), headache (1% to 5%), pain (1% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypercholesterolemia (1% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Dyspepsia (1% to 5%), gastrointestinal symptoms (1% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Prostate disorder (1% to 5%), urinary incontinence (1% to 5%), urinary tract infection (1% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Allergic reaction (1% to 5%), flu-like syndrome (1% to 5%), infection (1% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthritis (1% to 5%), back pain (1% to 5%), chest pain (1% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Decreased visual acuity (5% to 10%), eye discomfort (5% to 10%), foreign body sensation (5% to 10%), pain (5% to 10%), pruritus (5% to 10%), abnormal vision (1% to 4%), blepharitis (1% to 4%), blurred vision (1% to 4%), cataract (1% to 4%), conjunctivitis (1% to 4%), corneal staining (1% to 4%), dry eye (1% to 4%), eyelash darkening (1% to 4%), eyelash growth increased (1% to 4%), inflammation (1% to 4%), iris discoloration (1% to 4%), keratitis (1% to 4%), lid margin crusting (1% to 4%), periorbital skin discoloration (darkening) (1% to 4%), photophobia (1% to 4%), subconjunctival hemorrhage (1% to 4%), tearing (1% to 4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Bronchitis (1% to 5%), sinusitis (1% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports: Macular edema",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F230202\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to travoprost or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F230188\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bacterial keratitis: Inadvertent contamination of multiple-dose ophthalmic solutions, has caused bacterial keratitis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ocular effects: May permanently change/increase brown pigmentation of the iris, the eyelid skin, and eyelashes. In addition, may increase the length and/or number of eyelashes (may vary between eyes); changes occur slowly and may not be noticeable for months or years. Long-term consequences and potential injury to eye are not known.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ocular disease: Use with caution in patients with intraocular inflammation, aphakic patients, pseudophakic patients with a torn posterior lens capsule, or patients with risk factors for macular edema. Safety and efficacy have not been determined for use in patients with angle-closure-, inflammatory-, or neovascular glaucoma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pregnancy: Contact with contents of vial should be avoided in women who are pregnant or attempting to become pregnant; in case of accidental exposure to the skin, wash the exposed area with soap and water immediately.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300163\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6223400\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F230193\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F230205\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were observed in animal studies following systemic administration.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F230220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F230204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Travatan Z Ophthalmic)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.004% (2.5 mL): $115.62",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F230206\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Travatan (AR, AT, AU, BE, BG, BO, BR, CH, CL, CN, CO, CR, CZ, DE, DK, DO, EC, EE, ES, FI, FR, GB, GR, GT, HK, HN, ID, IE, IL, IT, KP, MT, MX, MY, NI, NL, NO, NZ, PA, PE, PH, PK, PL, PR, PT, PY, RU, SE, SG, SK, SV, TH, TR, TW, UY, VE, ZA)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F230187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A selective FP prostanoid receptor agonist which lowers intraocular pressure by increasing trabecular meshwork and outflow",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F230201\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: ~2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Peak effect: 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: Plasma levels decrease to &lt;10 pg/mL within 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Absorbed via cornea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hydrolyzed by esterases in the cornea to active free acid; systemically; the free acid is metabolized to inactive metabolites",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10055 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-200.215.4.194-8300F9CC1D-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_52_22339=[""].join("\n");
var outline_f21_52_22339=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230214\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230215\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230234\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230217\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230218\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230196\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230184\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230199\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230197\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230240\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230232\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230202\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230188\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300163\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6223400\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230193\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230205\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230220\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230204\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230206\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230187\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F230201\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10055\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10055|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?10/30/10724?source=related_link\">",
"      Travoprost: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_52_22340="Oxymetazoline (nasal): Pediatric drug information";
var content_f21_52_22340=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Oxymetazoline (nasal): Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?13/14/13541?source=see_link\">",
"    see \"Oxymetazoline (nasal): Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?23/25/23956?source=see_link\">",
"    see \"Oxymetazoline (nasal): Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block spa drugH1Div\" id=\"F15512120\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Special Alerts",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      FDA Issues Warning on Accidental Ingestion of Imidazoline Derivative Eye Drops and Nasal Sprays",
"     </span>",
"     <span class=\"collapsible-date\">",
"      October 2012",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       The U.S. Food and Drug Administration (FDA) has issued a warning that accidental ingestion by children of over-the-counter (OTC) imidazoline derivative eye drops and nasal sprays may result in serious harm. The eye drops and nasal sprays involved in cases of accidental ingestion contain the imidazoline derivatives tetrahydrozoline, oxymetazoline, or naphazoline. Serious adverse reactions (eg, coma, bradycardia, respiratory depression, sedation) requiring hospitalization were reported in children &le;5 years who had ingested even small amounts (eg, 1-2 mL). These products should be stored out of reach of children at all times; parents and caregivers should note that not all products are packaged in child-resistant packaging. If a child accidentally ingests these products, parents and caregivers should contact a poison control center at 1-800-222-1222 and seek emergency medical care immediately.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       For more information, please refer to:",
"       <a href=\"file://www.fda.gov/Drugs/DrugSafety/ucm325257.htm\" target=\"_blank\">",
"        file://www.fda.gov/Drugs/DrugSafety/ucm325257.htm",
"       </a>",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F9504215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      12 Hour Nasal Relief [OTC];",
"     </li>",
"     <li>",
"      4-Way&reg; 12 Hour [OTC];",
"     </li>",
"     <li>",
"      Afrin&reg; Extra Moisturizing [OTC];",
"     </li>",
"     <li>",
"      Afrin&reg; Original [OTC];",
"     </li>",
"     <li>",
"      Afrin&reg; Severe Congestion [OTC];",
"     </li>",
"     <li>",
"      Afrin&reg; Sinus [OTC];",
"     </li>",
"     <li>",
"      Dristan&reg; [OTC];",
"     </li>",
"     <li>",
"      Duramist Plus [OTC];",
"     </li>",
"     <li>",
"      Neo-Synephrine&reg; Nighttime12-Hour [OTC];",
"     </li>",
"     <li>",
"      Nostrilla&reg; [OTC];",
"     </li>",
"     <li>",
"      NRS&reg; [OTC];",
"     </li>",
"     <li>",
"      Vicks&reg; Sinex&reg; VapoSpray 12-Hour;",
"     </li>",
"     <li>",
"      Vicks&reg; Sinex&reg; VapoSpray 12-Hour UltraFine Mist [OTC];",
"     </li>",
"     <li>",
"      Vicks&reg; Sinex&reg; VapoSpray Moisturizing 12-Hour UltraFine Mist [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9504216\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Claritin&reg; Allergic Decongestant;",
"     </li>",
"     <li>",
"      Dristan&reg; Long Lasting Nasal;",
"     </li>",
"     <li>",
"      Drixoral&reg; Nasal",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F10512950\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Decongestant, Nasal",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Nasal Agent, Vasoconstrictor",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Vasoconstrictor, Nasal",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F10513031\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/14/13541?source=see_link\">",
"      see \"Oxymetazoline (nasal): Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Therapy should not exceed 3-5 days; avoid use in children &lt;6 years of age. Children &ge;6 years and Adults: 2-3 drops or 2-3 sprays or 1-2 metered sprays (N��strilla&reg;) into each nostril twice daily",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F9504460\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, intranasal, as hydrochloride [mist]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Original: 0.05% (15 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Vicks&reg; Sinex&reg; VapoSpray 12-Hour UltraFine Mist: 0.05% (15 mL) [contains benzalkonium chloride, menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Vicks&reg; Sinex&reg; VapoSpray Moisturizing 12-Hour UltraFine Mist: 0.05% (15 mL) [contains aloe, benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, intranasal, as hydrochloride [mist/no drip formula]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Extra Moisturizing: 0.05% (15 mL) [contains benzyl alcohol, glycerin]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Original: 0.05% (15 mL) [contains benzalkonium chloride, benzyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Severe Congestion: 0.05% (15 mL) [contains benzalkonium chloride, benzyl alcohol, camphor, menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Sinus: 0.05% (15 mL) [contains benzalkonium chloride, benzyl alcohol, camphor, menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, intranasal, as hydrochloride [spray]: 0.05% (15 mL, 30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     12 Hour Nasal Relief: 0.05% (15 mL, 30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     4-Way&reg; 12 Hour: 0.05% (15 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Extra Moisturizing: 0.05% (15 mL) [contains benzalkonium chloride, glycerin]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Original: 0.05% (15 mL, 30 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Severe Congestion: 0.05% (15 mL) [contains benzalkonium chloride, benzyl alcohol, camphor, menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Afrin&reg; Sinus: 0.05% (15 mL) [contains benzalkonium chloride, benzyl alcohol, camphor, menthol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dristan&reg;: 0.05% (15 mL) [contains benzalkonium chloride, benzyl alcohol]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Duramist Plus: 0.05% (15 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neo-Synephrine&reg; Nighttime12-Hour: 0.05% (15 mL) [contains benzalkonium chloride, glycerin]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Nostrilla&reg;: 0.05% (15 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     NRS&reg;: 0.05% (15 mL, 30 mL) [contains benzalkonium chloride]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Vicks&reg; Sinex&reg; VapoSpray 12-Hour: 0.05% (15 mL) [contains benzalkonium chloride]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F9504218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Intranasal solution (spray)",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F10513032\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Spray or apply drops into each nostril while gently occluding the other",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F10512951\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Symptomatic relief of nasal mucosal congestion associated with acute or chronic rhinitis, the common cold, sinusitis, hay fever, or other allergies",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9504320\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Oxymetazoline may be confused with oxymetholone",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Afrin&reg; may be confused with aspirin",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Afrin&reg; (oxymetazoline) may be confused with Afrin&reg; (saline)",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Neo-Synephrine&reg; (oxymetazoline) may be confused with Neo-Synephrine&reg; (phenylephrine, nasal)",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Accidental ingestion: Serious adverse reactions (eg, coma, bradycardia, respiratory depression, sedation) requiring hospitalization have been reported in children &le;5 years of age who have accidentally ingested even small amounts (eg, 1-2 mL) of imidazoline-derivative (ie, tetrahydrozoline, oxymetazoline, or naphazoline) eye drops or nasal sprays. Store these products out of reach of children at all times. Contact poison control or seek medical attention if accidental ingestion occurs.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F9504408\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;display:inline\">",
"     Respiratory: Dryness of the nasal mucosa, nasal irritation (temporary), rebound congestion (chronic use), sneezing",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10512952\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to oxymetazoline or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F10513004\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with hyperthyroidism, heart disease, hypertension, diabetes mellitus, or prostatic hypertrophy",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F10512990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use for periods exceeding 3 days may result in severe rebound nasal congestion; excessive dosage in children may cause profound CNS depression. Some products contain benzyl alcohol which may cause allergic reactions in susceptible individuals; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (\"gasping syndrome\") in neonates; the \"gasping syndrome\" consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate, a metabolite of benzyl alcohol, displaces bilirubin from protein binding sites; avoid use of these products in neonates",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F9504410\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Blockers: May diminish the hypertensive effect of Alpha1-Agonists. Similarly, Alpha1-Agonists may antagonize hypotensive effects of Alpha1-Blockers. Alpha1-Blockers may diminish the vasoconstricting effect of Alpha1-Agonists. Similarly, Alpha1-Agonists may antagonize Alpha1-Blocker vasodilation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: May enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ergot Derivatives: May enhance the hypertensive effect of Alpha1-Agonists. Ergot Derivatives may enhance the vasoconstricting effect of Alpha1-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ergoloid Mesylates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     FentaNYL: Alpha1-Agonists may decrease the serum concentration of FentaNYL. Specifically, fentanyl nasal spray serum concentrations may decrease and onset of effect may be delayed.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Sympathomimetics may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the hypertensive effect of Alpha1-Agonists.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: May enhance the vasopressor effect of Alpha1-Agonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F12711040\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse fetal or neonatal effects have not been observed following normal maternal doses of oxymetazoline during the third trimester of pregnancy. Adverse events have been noted in case reports following large doses or extended use. Decongestants are not the preferred agents for the treatment of rhinitis during pregnancy. Short-term (&lt;3 days) use of intranasal oxymetazoline may be beneficial to some patients although its safety during pregnancy has not been studied.",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F10513006\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stimulates alpha-adrenergic receptors in the arterioles of the nasal mucosa to produce vasoconstriction",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F10513029\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset of action: Within 5-10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Duration: 5-6 hours",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16035 Version 22.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-27.109.116.13-BBD231414A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_52_22340=[""].join("\n");
var outline_f21_52_22340=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15512120\">",
"      Special Alerts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504215\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504216\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10512950\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10513031\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504460\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504218\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10513032\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10512951\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504320\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504408\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10512952\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10513004\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10512990\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299804\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9504410\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12711040\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10513006\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10513029\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/16035\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/16035|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/14/13541?source=related_link\">",
"      Oxymetazoline (nasal): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?23/25/23956?source=related_link\">",
"      Oxymetazoline (nasal): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?9/46/9955?source=related_link\">",
"      Oxymetazoline (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?2/0/2052?source=related_link\">",
"      Oxymetazoline (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/40/32386?source=related_link\">",
"      Oxymetazoline (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_52_22341="Bimanual laryngoscopy";
var content_f21_52_22341=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F52096&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F52096&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bimanual laryngoscopy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Once the optimal glottic view is obtained with external laryngeal manipulation, the laryngoscopist instructs an assistant to place their fingers in exactly the same spot on the thyroid cartilage, using the same direction and degree of force.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Orebaugh SL. Direct laryngoscopy. In: Atlas of Airway Management: Techniques and Tools, Lippincott Williams &amp; Wilkins, Philadelphia 2007. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_52_22341=[""].join("\n");
var outline_f21_52_22341=null;
var title_f21_52_22342="Map of sub-Saharan Africa";
var content_f21_52_22342=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F68381&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F68381&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 528px\">",
"   <div class=\"ttl\">",
"    Map of sub-Saharan Africa",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 508px; height: 422px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The shaded areas demarcate sub-Saharan Africa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_52_22342=[""].join("\n");
var outline_f21_52_22342=null;
var title_f21_52_22343="Psychological stress and infertility";
var content_f21_52_22343=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Psychological stress and infertility",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/52/22343/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/52/22343/contributors\">",
"     Alice D Domar, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/52/22343/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/52/22343/contributors\">",
"     Jonathan M Silver, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?21/52/22343/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?21/52/22343/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?21/52/22343/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 15, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The belief that infertility is a psychologically mediated condition is long-standing. As an example, the Bible (1 Sam 1:1-28) describes Hannah, wife of Elkanah, as despondent and anorexic; she conceives only after she prays and is promised by a high priest that her wish will be granted [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/1\">",
"     1",
"    </a>",
"    ]. As health care professionals developed the ability to diagnose and treat most cases of infertility, they began to view it as an organic condition. Some infertility patients were told that their stress level had nothing to do with their ability to become pregnant and some health professionals did not assess the psychological status of their patients. However, there is evidence that stress levels influence the outcome of infertility treatment, as well as contribute to patients' decisions to continue treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/2\">",
"     2",
"    </a>",
"    ]. Stress also affects patients' reactions to pregnancy loss during infertility treatment and pregnancy complications. Moreover, psychological distress is associated with treatment failure and interventions to relieve stress are associated with increased pregnancy rates.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ASSESSMENT OF STRESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stress is defined as a stimulus which produces mental tension or physiological reaction, for the purposes of this review, the experience of infertility is the stimulus. Distress is the experience of anxiety or suffering, for the purposes of this review, the experience of infertility leads to the suffering",
"   </p>",
"   <p>",
"    Investigators have routinely utilized self-report questionnaires to evaluate the stress level of infertility patients. This approach may under-report the true level of distress since patients may feign emotional well-being in order to appear psychologically appropriate for infertility treatment. In research studies, the gold standard in psychological assessment is a structured personal interview with a trained mental health professional (psychiatrist or psychologist).",
"   </p>",
"   <p>",
"    Clinically, the provider can assess stress by observation of the patient and inquiring about the patient's emotional state. Research shows that the main sources of stress for infertility patients are the impact of infertility on their social life, their sexual health, and their relationships with their partner. Thus, questions which ask about each of these areas are recommended. These could include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Do you feel uncomfortable being around pregnant women",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      children or babies?",
"     </li>",
"     <li>",
"      Do you find that you try to avoid situations where there may be pregnant women or",
"      <span class=\"nowrap\">",
"       babies/small",
"      </span>",
"      children?",
"     </li>",
"     <li>",
"      Is your sexual relationship very satisfying, satisfying, or dissatisfying? And if it is dissatisfying, do you feel that your infertility has had a negative impact on your sex life?",
"     </li>",
"     <li>",
"      Do you only make love during the fertile times of your cycle?",
"     </li>",
"     <li>",
"      Do you feel that you and your partner mostly agree about how to proceed with infertility treatment?",
"     </li>",
"     <li>",
"      Do you feel that your partner is sympathetic and supportive of you?",
"     </li>",
"     <li>",
"      How is your mood? How have you been feeling? Are you able to enjoy your usual activities?",
"     </li>",
"     <li>",
"      Are you worried? Do you have difficulty concentrating or sleeping? Are you restless?",
"     </li>",
"     <li>",
"      Has your appetite changed?",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PREVALENCE OF STRESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychological stress appears to be more common in the partner with the fertility problem [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/3\">",
"     3",
"    </a>",
"    ]. The prevalence of psychological stress in infertility patients was illustrated in a study that used a psychiatrist to conduct structured personal interviews with 112 infertile women who were being seen for their first infertility clinic visit prior to medical evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/4\">",
"     4",
"    </a>",
"    ]. The Mini-International Neuropsychiatric Interview (MINI) was used to establish diagnoses. Forty percent of the patients met the criteria for a psychiatric disorder; the most common diagnosis was an anxiety disorder (23 percent), followed by major depressive disorder (17 percent). These findings reflect a much higher prevalence of psychiatric disorders in this sample of infertility patients than the 10 to 12 percent average prevalence of such symptoms in the primary care setting.",
"   </p>",
"   <p>",
"    A prior history of depression is a risk factor for recurrence of symptoms during infertility evaluation and therapy, although the exact prevalence is not known. However, it is known that women with a prior history of depression are at increased risk of experiencing infertility [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     IVF PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The level of stress in infertility patients tends to increase as treatment intensifies and as duration of treatment continues [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/6\">",
"     6",
"    </a>",
"    ]. Therefore, a population of in vitro fertilization (IVF) patients would be expected to experience more stress than women early in their infertility evaluation.",
"   </p>",
"   <p>",
"    Many IVF patients report depressive symptoms prior to beginning their cycle, which likely reflects the impact of repeated, unsuccessful, less invasive forms of treatment, but may reflect a prior history of",
"    <span class=\"nowrap\">",
"     mood/anxiety",
"    </span>",
"    disorders independent of infertility. As an example, one study showed that 54 percent of patients reported mild depressive symptoms prior to initiating an IVF cycle and 19 percent had moderate to severe levels [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/7\">",
"     7",
"    </a>",
"    ]. Since IVF is highly invasive and intensive, patient distress is not unanticipated. In fact, most IVF patients state that treatment is more of a psychological than a physical stressor [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/8\">",
"     8",
"    </a>",
"    ]. Nearly half of female IVF patients reported that infertility was the most upsetting experience of their lives [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most IVF patients report symptoms of depression, anxiety, anger, and isolation after unsuccessful treatment. Many of these symptoms persist over extended periods of time. In one retrospective study of 86 couples who did not conceive with IVF [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/10\">",
"     10",
"    </a>",
"    ], 66 percent of women and 40 percent of men reported symptoms of depression following their failed IVF treatment and one third of the respondents reported depressive symptoms 18 months later.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Impact of stress on drop out",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infertility specialists traditionally have assumed that patients drop out of treatment for only two reasons: active censoring (their physician advises the couple to terminate treatment due to a poor prognosis) and finances (since the procedure is often not covered by insurance). This assumption has been challenged; the psychological burden of the procedures appears to be the major reason for dropout.",
"   </p>",
"   <p>",
"    Active censoring is actually less common than previously thought. A study in the Netherlands, where IVF cycles are covered by insurance, showed a cumulative drop-out rate after three cycles of 62 percent, only 14 percent of which was due to active censoring [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/11\">",
"     11",
"    </a>",
"    ]. Most patients gave up because of passive censoring, which the authors defined as giving up treatment because of natural conception or personal reasons.",
"   </p>",
"   <p>",
"    Research also suggests that cost is not the motive for dropping out:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study of 974 couples in Sweden, 65 percent did not complete the three IVF cycles which were covered under their health plan [",
"      <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/12\">",
"       12",
"      </a>",
"      ]. The authors speculated that the high attrition rate was due to the physical and emotional burdens associated with IVF, but did not specifically ask couples why they discontinued treatment. A similar study on Australian couples had comparable results [",
"      <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/13\">",
"       13",
"      </a>",
"      ]. Couples were offered up to six cycles free of charge but the mean number of started cycles was only 3.1, whether or not a live birth was achieved. The most common reasons for terminating treatment were emotional (66 percent).",
"     </li>",
"     <li>",
"      Another study contacted 211 couples who had insurance coverage for IVF, but dropped out for reasons other than active censoring, and asked them for the main reason for their decision [",
"      <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/14\">",
"       14",
"      </a>",
"      ]. The most commonly cited reason was psychological burden, followed by the perception of poor prognosis. Patients who dropped out of treatment were as satisfied with their treatment as those who did not drop out. These findings were consistent with a similar study in which 515 patients who terminated treatment were contacted and asked to give the reason for their decision [",
"      <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/15\">",
"       15",
"      </a>",
"      ]. Once again, psychological stress was the most common reason cited, followed by lack of success.",
"     </li>",
"     <li>",
"      The impact of psychological stress on IVF outcome was also illustrated by a retrospective study of 2130 German patients [",
"      <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/16\">",
"       16",
"      </a>",
"      ]. Despite the fact that these patients were covered by insurance for four cycles, the drop-out rate of nonpregnant patients was 40 percent after the first cycle and 62 percent after the fourth. The author proposed that the increasing drop-out rate was attributable to the \"enormous stress and frustration\" during treatment, although this was an observation, the patients themselves were not surveyed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A patient's psychological state prior to treatment may be predictive of her drop-out behavior. In a prospective study, new patients were given a battery of psychological questionnaires prior to starting treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/17\">",
"     17",
"    </a>",
"    ]. Pretreatment levels of depression were highly predictive of patient drop-out behavior after only one cycle.",
"   </p>",
"   <p>",
"    In summary, the majority of insurance-covered patients voluntarily terminate treatment prior to completing their allotment of covered cycles. Not only are depressed patients more likely to drop out of treatment after only one cycle, but patients who prematurely terminated treatment cited psychological burden as the most common reason.",
"   </p>",
"   <p>",
"    Prematurely dropping out of treatment severely limits a couple's chance of conceiving. Infertility treatment has been offered to infertile couples for decades. Pregnancy rates from treatment have continued to rise, but the psychological aspects have been largely ignored. However, psychological issues may be far more important than previously thought. Distress levels in the female patient are significantly correlated to pregnancy rates. What is not known is what impact a psychological intervention may have on treatment termination decisions, as well as pregnancy rates.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Impact of stress on IVF outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since IVF is by far the most expensive and invasive form of infertility treatment, it is important to understand the impact of psychological distress on its outcome. It is concerning that the majority of patients report symptoms of anxiety",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    depression prior to commencing IVF treatment. If psychological distress can interfere with the success of treatment, and most patients report elevated levels of distress, then the impact of distress may be important. Research on the impact of distress on IVF outcome is more generalizable than for other infertility treatments since the protocol for IVF is comparable internationally.",
"   </p>",
"   <p>",
"    As discussed above, distress is one reason that couples drop out of IVF programs before achieving a pregnancy. In the previously described German study [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/16\">",
"     16",
"    </a>",
"    ], cumulative pregnancy rates if patients had not dropped out of treatment were estimated. The 2130 patients underwent a mean of only 1.92 cycles, even though the mean number of cycles to conception was 2.12; 49 percent underwent only one cycle. The real cumulative pregnancy rate was 31.4 percent after four cycles. Theoretically, if all nonpregnant patients had returned for only one more cycle, the cumulative pregnancy rate would have increased to 41 percent and if all non-pregnant patients had completed four cycles, the ongoing pregnancy rate would have been 53 percent, this would have increased to 60 percent after six cycles.",
"   </p>",
"   <p>",
"    Psychological stress may adversely affect IVF outcome in ways other than raising the drop out rate. At least 25 studies have addressed the",
"    <span class=\"nowrap\">",
"     distress/IVF",
"    </span>",
"    relationship: 16 found a significant relationship between preprocedure distress and subsequent pregnancy rates [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/7,10,18-32\">",
"     7,10,18-32",
"    </a>",
"    ], three noticed a trend [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/31,33,34\">",
"     31,33,34",
"    </a>",
"    ], four reported no relationship between distress and pregnancy outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/33,35-37\">",
"     33,35-37",
"    </a>",
"    ], and one study did not supply adequate data to draw any conclusions [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/38\">",
"     38",
"    </a>",
"    ]. The interpretation of some of this research is limited by methodological problems, including small sample sizes, measures of distress taken at different stages of treatment, use of different psychological questionnaires, and lack of adjustment for the potential impact of negative feedback. As an example, patients are aware of their ultrasound and laboratory results and understand when a good response has not been achieved. One would expect these patients to report higher levels of emotional distress, but, in the absence of baseline data, it can be difficult to determine whether the distress level led to poorer outcomes or whether patients who are experiencing a poor response to the medications (and thus have a poor prognosis) simply are reporting the resultant distress. However, many of the studies had solid research designs so that there are baseline data and the response to the medications is factored in.",
"   </p>",
"   <p>",
"    The best data on this subject comes from a prospective study in which 151 women were assessed prior to beginning an IVF or GIFT cycle [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. This was the first cycle for 66 percent of the sample. Participants completed a battery of psychological questionnaires at their first clinic visit and at the time of their procedure. Medical records were abstracted for information on the technical information about each cycle including the diagnosis, number of previous cycles, number of oocytes retrieved, fertilization rates, number of embryos transferred, embryo quality, presence or absence of a confirmed pregnancy, and pregnancy outcome.",
"   </p>",
"   <p>",
"    Major findings from this study were:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The baseline level of stress was significantly correlated with numerous biologic end points, including number of oocytes retrieved and fertilized, pregnancy, live birth rate, and birth weight.",
"     </li>",
"     <li>",
"      The stress level on the day of the procedure was significantly related only to the number of oocytes retrieved and fertilized.",
"     </li>",
"     <li>",
"      At baseline, the frequency of no live birth was 93 percent lower in women with the least distress compared to those with the most distress.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The authors concluded that patients should receive counseling, support, and education to decrease stress levels during the baseline period.",
"   </p>",
"   <p>",
"    A meta-analysis on this topic received widespread attention because it did not find a relationship between distress and conception in IVF patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/39\">",
"     39",
"    </a>",
"    ]. However, the authors included only 14 of the available studies; one of the largest studies included, which had negative results, has not yet been published. In addition, they prioritized &ldquo;state anxiety&rdquo; as their main measure of distress, despite the fact that patient distress was assessed up to three months prior to cycle start. &ldquo;State anxiety&rdquo; measures how anxious one is at that moment and thus is not an appropriate measure to be used far in advance of an event [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A subsequent study in this area highlights the complexity of the",
"    <span class=\"nowrap\">",
"     stress/IVF",
"    </span>",
"    outcome relationship. In this study, 148 women were followed prospectively through two IVF cycles [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/41\">",
"     41",
"    </a>",
"    ]. Half were randomized to attend a 10-session",
"    <span class=\"nowrap\">",
"     mind/body",
"    </span>",
"    program and the other half received usual care. All patients completed baseline psychological questionnaires prior to randomization and daily during their IVF cycles. Patients with moderate levels of distress at baseline were more likely to conceive than those with low levels at baseline. However, patients in the",
"    <span class=\"nowrap\">",
"     mind/body",
"    </span>",
"    intervention with moderate levels of distress at baseline were significantly more likely to conceive than control patients with moderate levels at baseline. It is possible that a moderate level of distress prior to cycle start is beneficial as long as patients have the opportunity to learn stress-reduction skills.",
"   </p>",
"   <p>",
"    The relationship between stress and outcome may depend on at the point in time the distress is assessed. Stress prior to cycle start may be beneficial, but distress during treatment may be detrimental.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     THERAPEUTIC INTERVENTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The assessment of the efficacy of psychological interventions in both reducing distress and increasing pregnancy rates has been hampered by inadequate research. A widely cited review of 380 published and unpublished papers on psychological interventions for infertility patients had only 25 independent evaluation studies [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/42\">",
"     42",
"    </a>",
"    ]. Results from these 25 studies suggested that psychosocial interventions could reduce negative affect and group interventions that emphasized education and skills training were highly effective in producing positive changes. However, this review did not find that psychosocial interventions impacted pregnancy rates. A subsequent review of this literature concluded that psychotherapy (either in a group or",
"    <span class=\"nowrap\">",
"     individual/couple",
"    </span>",
"    format) led to a reduction in anxiety and depression, as well as a possible increase in conception rates [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The first randomized, controlled, prospective trial limited to IVF patients assigned 60 couples to either an intervention or control group to assess the effectiveness of a psychological intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/44\">",
"     44",
"    </a>",
"    ]. Control subjects received routine care while the intervention group received what was termed the \"counseling service model.\" A nurse practitioner provided detailed information about what to expect during the cycle. They had daily phone contact with her, she was present during the egg retrieval and embryo transfer, and they met with her five times. The couples in the intervention group had statistically significant lower anxiety and depression scores, higher life satisfaction scores, and higher pregnancy rates (fetal heartbeat present) than the control group (43 versus 17 percent).",
"   </p>",
"   <p>",
"    A cognitive-behavioral approach for infertility patients has been utilized for almost 20 years. The first",
"    <span class=\"nowrap\">",
"     \"mind/body\"",
"    </span>",
"    infertility program was started in 1987 [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/45\">",
"     45",
"    </a>",
"    ] and since then, programs have been established worldwide [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/46\">",
"     46",
"    </a>",
"    ]. The content of these programs varies, but each generally contains relaxation techniques, stress-management, coping skills training, and group support. Programs range from 5 to 10 sessions, depending on the center, most include the male partners for at least several of the sessions, and are led by mental health professionals, nurses, or both. Participants report significant decreases in all assessed psychological and physical symptoms, including depression, anxiety, hostility, fatigue, headaches, insomnia, and abdominal pain [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/45\">",
"     45",
"    </a>",
"    ]. Approximately 45 percent of patients conceive within six months of program completion.",
"   </p>",
"   <p>",
"    This approach has been evaluated in infertility patients (not limited to IVF patients). In a single blinded trial, both symptom improvement and pregnancy rates were assessed in a group of 184 infertile women randomly assigned to a",
"    <span class=\"nowrap\">",
"     mind/body",
"    </span>",
"    10-session group program, a 10-session support group, or a routine care control group [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. Birth rates were significantly higher in the intervention groups: 55 percent in the",
"    <span class=\"nowrap\">",
"     mind/body",
"    </span>",
"    group, 54 percent in the support group, and 20 percent in the control group. There were also significant differences in psychological improvement: the",
"    <span class=\"nowrap\">",
"     mind/body",
"    </span>",
"    patients reported improvement, the support group reported no change, and the control subjects reporting an increase in symptoms over time.",
"   </p>",
"   <p>",
"    This study was repeated with IVF patients [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/49\">",
"     49",
"    </a>",
"    ]. A total of 143 women were randomized prior to beginning their first IVF cycle to attend a 10-session mind body program or to a routine care control group. Only 9 percent of the mind body patients had attended at least one half of their sessions at Cycle 1 start. Pregnancy rates for cycle 1 were 43 percent for both groups. For cycle 2, 76 percent of the mind body patients had attended at least one half of their sessions. Pregnancy rates for cycle 2 were 52 percent for the mind body patients and 20 percent for the controls.",
"   </p>",
"   <p>",
"    It is unclear why a psychological intervention might have a positive impact on pregnancy rates in infertile women. One possibility is that psychological stress affects biologic functions, such as immunology of the maternal-fetal interface (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/22/36201?source=see_link\">",
"     \"Immunology of the maternal-fetal interface\"",
"    </a>",
"    ). As an example, a randomized trial reported psychological distress and natural killer cell activity both decreased significantly in 37 women who received a five-session",
"    <span class=\"nowrap\">",
"     mind/body",
"    </span>",
"    intervention while there was no change in those who received routine care [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/50\">",
"     50",
"    </a>",
"    ]. During the one year follow-up period, 38 percent of the intervention subjects conceived, compared to 13.5 percent of the controls (p&lt;.03).",
"   </p>",
"   <p>",
"    Based on the data presented above, we and others feel the psychological status of infertility patients should be assessed, ideally through structured interviews with a mental health professional but at a minimum through the use of valid questionnaires, in order to relieve personal suffering and to possibly improve pregnancy rates [",
"    <a class=\"abstract\" href=\"UTD.htm?21/52/22343/abstract/2,42\">",
"     2,42",
"    </a>",
"    ]. Patients who express symptoms of anxiety",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    depression should be treated. We suggest relaxation techniques, stress-management, coping skills training, and group support as initial therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29751?source=see_link\">",
"     \"Overview of psychotherapies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pharmacotherapy may be indicated in cases in which psychological treatment has not been effective and the symptoms of anxiety",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    depression are significant. It is important to refer these patients for a psychopharmacological evaluation since the half life of antidepressants differ, and many infertility patients will be able to taper off their medications once a pregnancy is established. Women with a history of treatment for depression",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    anxiety should be carefully evaluated prior to commencing infertility treatment. Many patients decide to discontinue their medications prior to trying to conceive and their symptoms may thus return and complicate what is already a difficult psychological situation. These patients need to be evaluated by a psychiatrist to receive recommendations on the risks and benefits of taking medications. In addition, the clinician needs to be aware of situations that might make patients more prone to experiencing psychiatric symptoms, such as depression or anxiety. In general, patients at increased risk are women with a history of psychiatric illness, who have experienced pregnancy loss(es), with longer histories of infertility, and with definitive medical diagnoses for their infertility that might lead to poorer prognoses (eg, premature ovarian failure, severe endometriosis). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/2/29735?source=see_link\">",
"     \"Depression in pregnant women: Clinical features and consequences\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are many mental health professionals who have specific expertise in diagnosing and treating the unique challenges faced by infertile individuals and couples. A listing of mental health professionals with experience infertility patients can be found at the following websites:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"external\" href=\"file://www.asrm.org/\">",
"       www.ASRM.org",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.resolve.org/\">",
"       www.Resolve.org",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infertile women experience high levels of stress, frequently manifested as symptoms of anxiety",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      depression. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Prevalence of stress'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Psychological discomfort appears to lead to premature termination of in vitro fertilization treatment and thus to reduce pregnancy rates. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'IVF patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Psychological interventions lead to a decrease in psychological symptoms and appear to increase pregnancy rates. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Therapeutic interventions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The optimal approach to psychological intervention has not been determined. We suggest relaxation techniques, stress-management, coping skills training, and group support (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Evaluation by a psychiatrist for consideration of pharmacotherapy is indicated in women with significant symptoms of anxiety or depression. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Therapeutic interventions'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/1\">",
"      Schiff I, Schiff M. The biblical diagnostician and the anorexic bride. Fertil Steril 1998; 69:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/2\">",
"      Campagne DM. Should fertilization treatment start with reducing stress? Hum Reprod 2006; 21:1651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/3\">",
"      Dhaliwal LK, Gupta KR, Gopalan S, Kulhara P. Psychological aspects of infertility due to various causes--prospective study. Int J Fertil Womens Med 2004; 49:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/4\">",
"      Chen TH, Chang SP, Tsai CF, Juang KD. Prevalence of depressive and anxiety disorders in an assisted reproductive technique clinic. Hum Reprod 2004; 19:2313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/5\">",
"      Lapane KL, Zierler S, Lasater TM, et al. Is a history of depressive symptoms associated with an increased risk of infertility in women? Psychosom Med 1995; 57:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/6\">",
"      Domar AD, Broome A, Zuttermeister PC, et al. The prevalence and predictability of depression in infertile women. Fertil Steril 1992; 58:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/7\">",
"      Demyttenaere K, Bonte L, Gheldof M, et al. Coping style and depression level influence outcome in in vitro fertilization. Fertil Steril 1998; 69:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/8\">",
"      Eugster A, Vingerhoets AJ. Psychological aspects of in vitro fertilization: a review. Soc Sci Med 1999; 48:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/9\">",
"      Freeman EW, Boxer AS, Rickels K, et al. Psychological evaluation and support in a program of in vitro fertilization and embryo transfer. Fertil Steril 1985; 43:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/10\">",
"      Baram, D, Tourtelot, E, Muechler, E, Huang, K. Psychological adjustment following unsuccessful in vitro fertilization. J Psychosom Obstet Gynecol 1988; 8:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/11\">",
"      Land JA, Courtar DA, Evers JL. Patient dropout in an assisted reproductive technology program: implications for pregnancy rates. Fertil Steril 1997; 68:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/12\">",
"      Olivius K, Friden B, Lundin K, Bergh C. Cumulative probability of live birth after three in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril 2002; 77:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/13\">",
"      Hammarberg K, Astbury J, Baker H. Women's experience of IVF: a follow-up study. Hum Reprod 2001; 16:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/14\">",
"      Olivius C, Friden B, Borg G, Bergh C. Why do couples discontinue in vitro fertilization treatment? A cohort study. Fertil Steril 2004; 81:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/15\">",
"      Rajkhowa M, McConnell A, Thomas GE. Reasons for discontinuation of IVF treatment: a questionnaire study. Hum Reprod 2006; 21:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/16\">",
"      Schr&ouml;der AK, Katalinic A, Diedrich K, Ludwig M. Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients. Reprod Biomed Online 2004; 8:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/17\">",
"      Smeenk JM, Verhaak CM, Stolwijk AM, et al. Reasons for dropout in an in vitro fertilization/intracytoplasmic sperm injection program. Fertil Steril 2004; 81:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/18\">",
"      Boivin J, Schmidt L. Infertility-related stress in men and women predicts treatment outcome 1 year later. Fertil Steril 2005; 83:1745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/19\">",
"      Boivin J, Takefman JE. Stress level across stages of in vitro fertilization in subsequently pregnant and nonpregnant women. Fertil Steril 1995; 64:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/20\">",
"      Creac'h-Le Mer, M, Stoleru, S, Cornet, D, Zerah, S, Fermanian, J, Bimbard, S, Spira, A. Women's anxiety is a predictor of the implantation step of in vitro fertilization. Psychosom Med 1999; 61:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/21\">",
"      Facchinetti F, Matteo ML, Artini GP, et al. An increased vulnerability to stress is associated with a poor outcome of in vitro fertilization-embryo transfer treatment. Fertil Steril 1997; 67:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/22\">",
"      Gallinelli A, Roncaglia R, Matteo ML, et al. Immunological changes and stress are associated with different implantation rates in patients undergoing in vitro fertilization-embryo transfer. Fertil Steril 2001; 76:85.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/23\">",
"      Kee BS, Jung BJ, Lee SH. A study on psychological strain in IVF patients. J Assist Reprod Genet 2000; 17:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/24\">",
"      Kemeter P. Studies on psychosomatic implications of infertility--effects of emotional stress on fertilization and implantation in in-vitro fertilization. Hum Reprod 1988; 3:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/25\">",
"      Klonoff-Cohen H, Chu E, Natarajan L, Sieber W. A prospective study of stress among women undergoing in vitro fertilization or gamete intrafallopian transfer. Fertil Steril 2001; 76:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/26\">",
"      Klonoff-Cohen H, Natarajan L. The concerns during assisted reproductive technologies (CART) scale and pregnancy outcomes. Fertil Steril 2004; 81:982.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/27\">",
"      Merari, D, Feldberg, D, Shitrit, A, Elizur, A, Modan, B. Psychological characteristics of women undergoing in vitro fertilization: a study of treatment outcome. Israel J Obstet Gynecol 1996; 7:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/28\">",
"      Sanders KA, Bruce NW. Psychosocial stress and treatment outcome following assisted reproductive technology. Hum Reprod 1999; 14:1656.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/29\">",
"      Smeenk JM, Verhaak CM, Eugster A, et al. The effect of anxiety and depression on the outcome of in-vitro fertilization. Hum Reprod 2001; 16:1420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/30\">",
"      Stol&eacute;ru S, Cornet D, Vaugeois P, et al. The influence of psychological factors on the outcome of the fertilization step of in vitro fertilization. J Psychosom Obstet Gynaecol 1997; 18:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/31\">",
"      Thiering P, Beaurepaire J, Jones M, et al. Mood state as a predictor of treatment outcome after in vitro fertilization/embryo transfer technology (IVF/ET). J Psychosom Res 1993; 37:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/32\">",
"      Verhaak CM, Smeenk JM, Eugster A, et al. Stress and marital satisfaction among women before and after their first cycle of in vitro fertilization and intracytoplasmic sperm injection. Fertil Steril 2001; 76:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/33\">",
"      Harlow CR, Fahy UM, Talbot WM, et al. Stress and stress-related hormones during in-vitro fertilization treatment. Hum Reprod 1996; 11:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/34\">",
"      Csemiczky G, Landgren BM, Collins A. The influence of stress and state anxiety on the outcome of IVF-treatment: psychological and endocrinological assessment of Swedish women entering IVF-treatment. Acta Obstet Gynecol Scand 2000; 79:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/35\">",
"      Lovely LP, Meyer WR, Ekstrom RD, Golden RN. Effect of stress on pregnancy outcome among women undergoing assisted reproduction procedures. South Med J 2003; 96:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/36\">",
"      Slade P, Emery J, Lieberman BA. A prospective, longitudinal study of emotions and relationships in in-vitro fertilization treatment. Hum Reprod 1997; 12:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/37\">",
"      Merari D, Feldberg D, Elizur A, et al. Psychological and hormonal changes in the course of in vitro fertilization. J Assist Reprod Genet 1992; 9:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/38\">",
"      Salvatore P, Gariboldi S, Offidani A, et al. Psychopathology, personality, and marital relationship in patients undergoing in vitro fertilization procedures. Fertil Steril 2001; 75:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/39\">",
"      Boivin J, Griffiths E, Venetis CA. Emotional distress in infertile women and failure of assisted reproductive technologies: meta-analysis of prospective psychosocial studies. BMJ 2011; 342:d223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/40\">",
"      Lynch CD, Domar AD. Meta-analysis is not the final word on the effect of emotional distress on fertility treatment outcomes. BMJ 2011.",
"     </a>",
"    </li>",
"    <li>",
"     Domar AD, Backman KL, Friscia D, Alper MM, Berger BM, Nikolovski J. The relationship between stress and IVF outcome. Presented at the annual meeting of the American Society of Reproductive Medicine, Denver CO, October 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/42\">",
"      Boivin J. A review of psychosocial interventions in infertility. Soc Sci Med 2003; 57:2325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/43\">",
"      de Liz TM, Strauss B. Differential efficacy of group and individual/couple psychotherapy with infertile patients. Hum Reprod 2005; 20:1324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/44\">",
"      Terzioglu F. Investigation into effectiveness of counseling on assisted reproductive techniques in Turkey. J Psychosom Obstet Gynaecol 2001; 22:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/45\">",
"      Domar AD, Seibel MM, Benson H. The mind/body program for infertility: a new behavioral treatment approach for women with infertility. Fertil Steril 1990; 53:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/46\">",
"      Lemmens GM, Vervaeke M, Enzlin P, et al. Coping with infertility: a body-mind group intervention programme for infertile couples. Hum Reprod 2004; 19:1917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/47\">",
"      Domar AD, Clapp D, Slawsby EA, et al. Impact of group psychological interventions on pregnancy rates in infertile women. Fertil Steril 2000; 73:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/48\">",
"      Domar AD, Clapp D, Slawsby E, et al. The impact of group psychological interventions on distress in infertile women. Health Psychol 2000; 19:568.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/49\">",
"      Domar AD, Rooney KL, Wiegand B, et al. Impact of a group mind/body intervention on pregnancy rates in IVF patients. Fertil Steril 2011; 95:2269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?21/52/22343/abstract/50\">",
"      Hosaka T, Matsubayashi H, Sugiyama Y, et al. Effect of psychiatric group intervention on natural-killer cell activity and pregnancy rate. Gen Hosp Psychiatry 2002; 24:353.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4859 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-7DB0BEB7E6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_52_22343=[""].join("\n");
var outline_f21_52_22343=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ASSESSMENT OF STRESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PREVALENCE OF STRESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      IVF PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Impact of stress on drop out",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Impact of stress on IVF outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      THERAPEUTIC INTERVENTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/2/29735?source=related_link\">",
"      Depression in pregnant women: Clinical features and consequences",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/22/36201?source=related_link\">",
"      Immunology of the maternal-fetal interface",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29751?source=related_link\">",
"      Overview of psychotherapies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_52_22344="Subungual fibroma";
var content_f21_52_22344=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85597%7EDERM%2F85598&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85597%7EDERM%2F85598&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Subungual fibroma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Nail fibroma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_52_22344=[""].join("\n");
var outline_f21_52_22344=null;
var title_f21_52_22345="Linezolid: Pediatric drug information";
var content_f21_52_22345=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Linezolid: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"    see \"Linezolid: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?1/30/1510?source=see_link\">",
"    see \"Linezolid: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F188966\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Zyvox&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F188967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Zyvoxam&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1048288\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Oxazolidinone",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11443849\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      General dosing, susceptible infection",
"     </b>",
"     (",
"     <i>",
"      Red Book",
"     </i>",
"     , 2012): I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Body weight &le;2 kg:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     PNA &le;7 days: 10 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     PNA 8-28 days: 10 mg/kg/dose every 8 hours;",
"     <b>",
"      Note:",
"     </b>",
"     For ELBW neonates (body weight: &lt;1 kg) and PNA &le;14 days, may consider an extended dosing interval.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Body weight &gt;2 kg: 10 mg/kg/dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Bacteremia:",
"     </b>",
"     Oral, I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Treatment should continue for 10-28 days depending on the organism",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     GA &lt;34 weeks:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     PNA &lt;7 days: 10 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     PNA &ge;7 days: 10 mg/kg/dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     GA &ge;34 weeks and PNA 0-28 days:10 mg/kg/dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Pneumonia, community- or hospital-acquired:",
"     </b>",
"     Oral, I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Treatment should continue for 10-14 days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     GA &lt;34 weeks:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     PNA &lt;7 days: 10 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     PNA &ge;7 days: 10 mg/kg/dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     GA &ge;34 weeks and PNA 0-28 days: 10 mg/kg/dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Skin and skin structure infections, complicated and uncomplicated:",
"     </b>",
"     Oral, I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Treatment should continue for 10-14 days; reserve I.V. use for complicated infections only.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     GA &lt;34 weeks:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     PNA &lt;7 days: 10 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     PNA &ge;7 days: 10 mg/kg/dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     GA &ge;34 weeks and PNA 0-28 days: 10 mg/kg/dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Vancomycin-resistant",
"      <i>",
"       Enterococcus faecium",
"      </i>",
"      (VREF) infection:",
"     </b>",
"     Oral, I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Treatment should continue for 14-28 days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     GA &lt;34 weeks:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     PNA &lt;7 days: 10 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     PNA &ge;7 days: 10 mg/kg/dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     GA &ge;34 weeks and PNA 0-28 days: 10 mg/kg/dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Case reports describe the use of higher doses up to 12-15 mg/kg/dose every 8 hours to treat VRE endocarditis and meningitis/ventriculitis  in former premature neonates (n=2; GA: 26, 35 weeks; age at treatment: Term) (Ang, 2003; Kumar, 2007).",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1048281\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"      see \"Linezolid: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants, Children, and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      General dosing, susceptible infection (mild, moderate, or severe)",
"     </b>",
"     (",
"     <i>",
"      Red Book",
"     </i>",
"     , 2012): Oral, I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants and Children &lt;12 years: 10 mg/kg/dose every 8 hours, maximum dose: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &ge;12 years and Adolescents: 600 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Bacteremia:",
"     </b>",
"     Oral, I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Treatment should continue for 10-28 days depending on the organism.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants and Children &lt;12 years: 10 mg/kg/dose every 8 hours; maximum dose: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &ge;12 years and Adolescents: 600 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Bone and joint infection",
"     </b>",
"     (Liu, 2011):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Osteomyelitis [",
"     <i>",
"      S. aureus",
"     </i>",
"     (methicillin-resistant)]: Oral, I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Treatment should continue for a minimum of 4-6 weeks.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Infants and Children &lt;12 years: 10 mg/kg/dose every 8 hours; maximum dose: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Children &ge;12 years and Adolescents: 600 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Septic arthritis [",
"     <i>",
"      S. aureus",
"     </i>",
"     (methicillin-resistant)]: Oral, I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Treatment should continue for a minimum of 3-4 weeks.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Infants and Children &lt;12 years: 10 mg/kg/dose every 8 hours; maximum dose: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Children &ge;12 years and Adolescents: 600 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Catheter-related infections, Staphylococcal (methicillin-resistant) or enterococcal (resistant) (confirmed infection):",
"     </b>",
"     Oral, I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Not recommended use for empiric treatment (Mermel, 2009).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants and Children &lt;12 years: 10 mg/kg/dose every 8 hours; maximum dose: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &ge;12 years and Adolescents: 10 mg/kg/dose every 12 hours; maximum dose: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      CNS infection:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Brain abscess, subdural empyema, spinal epidural abscess [",
"     <i>",
"      S. aureus",
"     </i>",
"     (methicillin-resistant)]:  Oral, I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Treatment should continue for 4-6 weeks (Liu, 2011).",
"     <b>",
"      Note:",
"     </b>",
"     The manufacturer does not recommend the use of linezolid for empiric treatment of pediatric CNS infections since therapeutic linezolid concentrations are not consistently achieved or maintained in the CSF of patients with ventriculoperitoneal shunts.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Infants and Children &lt;12 years: 10 mg/kg/dose every 8 hours; maximum dose: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Children &ge;12 years and Adolescents: 600 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Meningitis [",
"     <i>",
"      S. aureus",
"     </i>",
"     (methicillin-resistant)]: Oral, I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Treatment should continue for 2 weeks (Liu, 2011; Tunkel, 2004).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Infants and Children &lt;12 years: 10 mg/kg/dose every 8 hours; maximum dose: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Children &ge;12 years and Adolescents: 600 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Endocarditis, treatment [",
"      <i>",
"       E. faecium",
"      </i>",
"      (vancomycin-resistant)]:",
"     </b>",
"     Oral, I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Treatment should continue for at least 8 weeks (Baddour, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants and Children &lt;12 years: 10 mg/kg/dose every 8 hours; maximum dose: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &ge;12 years and Adolescents: 600 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Pneumonia",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Community- or hospital-acquired (non-MRSA): Oral, I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Treatment should continue for 10-14 days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Infants and Children &lt;12 years: 10 mg/kg/dose every 8 hours; maximum dose: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Children &ge;12 years and Adolescents: 600 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      S. aureus",
"     </i>",
"     (methicillin-resistant): Oral, I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Treatment should continue for 7-21 days depending on severity (Liu, 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants and Children &lt;12 years: 10 mg/kg/dose every 8 hours; maximum dose: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &ge;12 years and Adolescents: 600 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Septic thrombosis of cavernous or dural venous sinus [",
"      <i>",
"       S. aureus",
"      </i>",
"      (methicillin-resistant)]:",
"     </b>",
"     Oral, I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Treatment should continue for 4-6 weeks (Liu, 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants and Children &lt;12 years: 10 mg/kg/dose every 8 hours; maximum dose: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &ge;12 years and Adolescents: 600 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Skin and skin structure infections: Note:",
"     </b>",
"     Treatment should continue for 10-14 days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Uncomplicated:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Infants and Children &lt;5 years: Oral: 10 mg/kg/dose every 8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Children 5-11 years: Oral: 10 mg/kg/dose every 12 hours; maximum dose: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Children &ge;12 years and Adolescents: Oral: 600 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Complicated:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Infants and Children &lt;12 years: Oral, I.V.: 10 mg/kg/dose every 8 hours; maximum dose: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Children &ge;12 years and Adolescents: Oral, I.V.: 600 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Tuberculosis, multidrug-resistant:",
"     </b>",
"     Limited data available: Oral:",
"     <b>",
"      Note:",
"     </b>",
"     Experience in pediatric patients reflects extrapolation of dosing approach used in adult patients which includes a lower daily dose to decrease risk of adverse effects due to the anticipated long duration of therapy and if toxicity does occur, further dosage reductions (a 25% to 50% dose decrease or increased dosing interval have been used); reported treatment duration dependent upon clinical course; reported range: 13-36 months in pediatric patients. All reports describe linezolid as part of a multidrug antimycobacterial regimen; other reported agents within the combination therapy were variable, dependent upon specific organism sensitivities, and generally included 3-5 other agents. Further studies are needed.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants &ge;4 months and Children: 10-12 mg/kg/dose twice daily; maximum dose: 600 mg; dosing based on case reports describing successful treatment in infants and a young child (n=3; ages: 4.5 months, 11 months, and 23 months) (Pinon, 2010; Schaaf, 2009). Use has also been reported in a 10-year old child, treatment was successfully completed with dosing of 600 mg once daily (Condos, 2008).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adolescents: 600 mg once daily was reported in a retrospective review of 30 patients (n= 4 adolescents) and a case report (patient age: 14 years) (Dauby, 2011; Schecter, 2010).  In another case series, 600 mg twice daily dosing was used for the initial 2 weeks of therapy and then decreased to once daily dosing; at reduced dosage, patients seemed to have decreased hematologic toxicity while neurotoxicity remained unchanged (Park, 2006).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Vancomycin-resistant",
"      <i>",
"       Enterococcus faecium",
"      </i>",
"      (VREF) infections:",
"     </b>",
"     Oral, I.V.:",
"     <b>",
"      Note:",
"     </b>",
"     Treatment should continue for 14-28 days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants and Children &lt;12 years: 10 mg/kg/dose every 8 hours, maximum dose: 600 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &ge;12 years and Adolescents: Oral, I.V.: 600 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Usual dosage:",
"     </b>",
"     Oral, I.V.: 600 mg every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Indication-specific dosing:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      MRSA infections",
"     </b>",
"     (Liu, 2011): Oral, I.V.:  600 mg every 12 hours; duration of therapy dependent upon site of infection and clinical response",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Pneumonia, community- or hospital-acquired:",
"     </b>",
"     Oral, I.V.: 600 mg every 12 hours for 10-14 days.",
"     <b>",
"      Note:",
"     </b>",
"     In contrast to the manufacturer&rsquo;s recommendations, current guidelines for the treatment of community-acquired, healthcare-, hospital-, and ventilator-associated pneumonia recommend that the duration of therapy be reduced to as short as 7 days (vs 10-14 days) in patients who demonstrate good clinical response (ATS/IDSA, 2005; ATS/IDSA, 2011).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Skin and skin structure infections",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Complicated: Oral, I.V.: 600 mg every 12 hours for 10-14 days.",
"     <b>",
"      Note:",
"     </b>",
"     For diabetic foot infections, initial treatment duration is up to 4 weeks depending on severity of infection and response to therapy (Lipsky, 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Uncomplicated: Oral: 400 mg every 12 hours for 10-14 days.",
"     <b>",
"      Note:",
"     </b>",
"     400 mg dose is recommended in the product labeling; however, 600 mg dose is commonly employed clinically; consider 5- to 10-day treatment course as opposed to the manufacturer recommended 10-14 days (Liu, 2011; Stevens, 2005). For diabetic foot infections, may extend treatment duration up to 4 weeks if slow to resolve (Lipsky, 2012).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      VREF infections, including concurrent bacteremia:",
"     </b>",
"     Oral, I.V.: 600 mg every 12 hours for 14-28 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"     No adjustment is recommended. The two primary metabolites may accumulate in patients with renal impairment but the clinical significance is unknown. Weigh the risk of accumulation of metabolites versus the benefit of therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants, Children, and Adolescents: The following adjustments have been recommended (Aronoff, 2007):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Intermittent hemodialysis: 10 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Peritoneal dialysis (PD): 10 mg/kg/dose every 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Continuous renal replacement therapy (CRRT): No adjustment necessary",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: Intermittent hemodialysis (administer after hemodialysis on dialysis days): Dialyzable (~30% removed during 3-hour dialysis session): If administration time is not immediately after dialysis session, may consider administration of a supplemental dose especially early in the treatment course to maintain levels above the MIC (Brier, 2003). Others have recommended no supplemental dose or dosage adjustment for patients on intermittent hemodialysis, peritoneal dialysis, or continuous renal replacement therapy (eg, CVVHD) (Heintz, 2009; Trotman, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in hepatic impairment:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Mild to moderate impairment (Child Pugh class A or B): No adjustment is recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Severe hepatic impairment (Child Pugh Class C): Use has not been adequately evaluated.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F188942\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion, premixed:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zyvox&reg;: 200 mg (100 mL); 600 mg (300 mL) [contains sodium 0.38 mg/mL]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for suspension, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zyvox&reg;: 100 mg/5 mL (150 mL) [contains phenylalanine 20 mg/5 mL, sodium 8.52 mg (0.4 mEq)/5 mL, sodium benzoate; orange flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Zyvox&reg;: 600 mg [contains sodium 2.92 mg (0.1 mEq)/tablet]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F188927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1048291\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Administer with or without food. With reconstituted suspension, gently invert bottle 3-5 times before use. Do not shake.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral: I.V.: Check infusion bag for minute leaks and solution for particulate matter prior to administration. The 2 mg/mL infusion should be administered without further dilution over 30-120 minutes. Flush line before and after infusion with a linezolid-compatible I.V. solution like D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS, or LR.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F189000\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     1/2 NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, LR, NS",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Acyclovir, alfentanil, amikacin, aminophylline, ampicillin, ampicillin/sulbactam, anidulafungin, aztreonam, buprenorphine, butorphanol, calcium gluconate, carboplatin, caspofungin, cefazolin, cefotetan, cefoxitin, ceftazidime, cefuroxime, cimetidine, ciprofloxacin, cisatracurium, cisplatin, clindamycin, cyclophosphamide, cyclosporine, cytarabine, dexamethasone sodium phosphate, dexmedetomidine, digoxin, diphenhydramine, dobutamine, dopamine, doripenem, doxorubicin, doxycycline, droperidol, enalaprilat, erythromycin lactobionate, esmolol, etoposide phosphate, famotidine, fenoldopam, fentanyl, fluconazole, fluorouracil, furosemide, ganciclovir, gemcitabine, gentamicin, granisetron, haloperidol, heparin, hydrocortisone sodium succinate, hydromorphone, hydroxyzine, ifosfamide, imipenem/cilastatin, labetalol, leucovorin calcium, levofloxacin, lidocaine, lorazepam, magnesium sulfate, mannitol, meperidine, meropenem, mesna, methotrexate, methylprednisolone sodium succinate, metoclopramide, metronidazole, midazolam, minocylcine, mitoxantrone, morphine, nalbuphine, naloxone, nicardipine, nitroglycerin, ondansetron, paclitaxel, pentobarbital, phenobarbital, piperacillin, piperacillin/tazobactam, potassium chloride, prochlorperazine, promethazine, propranolol, ranitidine, remifentanil, sodium bicarbonate, sufentanil, sulfamethoxazole/trimethoprim, theophylline, tigecycline, tobramycin, vancomycin, vasopressin, vecuronium, verapamil, vincristine, zidovudine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Amphotericin B, chlorpromazine, diazepam, pentamidine, phenytoin.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Ceftriaxone.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Incompatible:",
"     </b>",
"     Ceftriaxone.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1048284\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at 25&ordm;C (77&ordm;F); excursions permitted to 15&deg;C to 30&ordm;C (59&deg;F to 86&ordm;F); protect from light.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection (premix infusion): Do not freeze. Store in overwrap until ready for use. The yellow color of the injectable solution may intensify over time without adversely affecting potency.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral suspension: Store reconstituted oral suspension at room temperature and use within 21 days.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablets: Protect from moisture.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1048290\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of community-acquired pneumonia, hospital-acquired pneumonia, uncomplicated and complicated skin and soft tissue infections (including diabetic foot infections without concomitant osteomyelitis), and bacteremia caused by susceptible organisms, such as vancomycin-resistant",
"     <i>",
"      Enterococcus faecium",
"     </i>",
"     (VREF),",
"     <i>",
"      Streptococcus pneumoniae",
"     </i>",
"     including multidrug resistant strains,",
"     <i>",
"      Staphylococcus aureus",
"     </i>",
"     including MRSA,",
"     <i>",
"      Streptococcus pyogenes",
"     </i>",
"     , or",
"     <i>",
"      Streptococcus agalactiae",
"     </i>",
"     (FDA approved in all ages).",
"     <b>",
"      Note:",
"     </b>",
"     There have been reports of vancomycin-resistant",
"     <i>",
"      E. faecium",
"     </i>",
"     and",
"     <i>",
"      S. aureus",
"     </i>",
"     (methicillin-resistant) developing resistance to linezolid during its clinical use.",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F189002\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Zyvox&reg; may be confused with Zosyn&reg;, Zovirax&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F188999\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, fever, headache, insomnia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Amylase increased, constipation, diarrhea, lipase increased, nausea, oral moniliasis, pancreatitis, taste alteration, tongue discoloration, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Vaginal moniliasis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Hemoglobin decreased, leukopenia, neutropenia, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: ALT increased, AST increased, alkaline phosphatase increased, bilirubin increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: BUN increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Fungal infection, lactate dehydrogenase increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Anaphylaxis, anemia, angioedema, bullous skin disorders, creatinine increased,",
"     <i>",
"      C. difficile",
"     </i>",
"     -related complications, dyspepsia, hypertension, hypoglycemia, lactic acidosis, localized abdominal pain, optic neuropathy, pancytopenia, peripheral neuropathy, pruritus, rhabdomyolysis, seizures, serotonin syndrome (with concurrent use of other serotonergic agents), Stevens-Johnson syndrome, tooth discoloration, vision loss",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1048294\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to linezolid or any component; concurrent use or within 2 weeks of MAO inhibitors; patients with uncontrolled hypertension, pheochromocytoma, thyrotoxicosis, and/or taking sympathomimetics (eg, pseudoephedrine), vasopressive agents (eg, epinephrine, norepinephrine), or dopaminergic agents (eg, dopamine, dobutamine) unless closely monitored for increased blood pressure; patients with carcinoid syndrome and/or taking SSRIs, tricyclic antidepressants, serotonin 5-HT",
"     <sub>",
"      1B, 1D",
"     </sub>",
"     receptor agonists, meperidine, or buspirone unless closely monitored for sign/symptoms of serotonin syndrome",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1048280\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution and monitor closely in patients with uncontrolled hypertension, untreated hyperthyroidism, carcinoid syndrome, or pheochromocytoma; linezolid has not been studied in patients with these conditions; use is contraindicated if close monitoring unavailable. Use with caution in patients with a history of or risk factors for seizures; seizures have been reported with use. Use with caution in renal impairment; while no adjustment recommended, the two primary metabolites may accumulate in patients with renal impairment; the clinical significance is unknown; risk of accumulation of metabolites versus the benefit of therapy should be weighed; monitor for hematopoietic and neuropathic adverse events when administering for extended periods in patients with renal impairment. Use with caution in severe hepatic impairment (Child-Pugh class C); use has not been adequately evaluated.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Linezolid suspension contains aspartame which is metabolized to phenylalanine and must be used with caution in patients with phenylketonuria.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1048279\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Linezolid is a reversible, nonselective MAO inhibitor with the potential to have the same interactions as other MAO inhibitors. May cause serotonin syndrome; symptoms include agitation, confusion, hallucinations, hyper-reflexia, myoclonus, shivering, and tachycardia, may occur with concomitant proserotonergic drugs (eg, SSRIs/SNRIs or triptans) or agents which reduce linezolid's metabolism; concurrent use with these medications is contraindicated unless patient is closely monitored for signs/symptoms of serotonin syndrome. Hypoglycemic episodes have been reported; use with caution and closely monitor glucose in diabetic patients; dose reductions/discontinuation of concurrent hypoglycemic agents or discontinuation of linezolid may be required. Thrombocytopenia, anemia, leukopenia, and pancytopenia have been reported in patients receiving linezolid and may be dependent on duration of therapy (generally &gt;2 weeks of treatment); monitor patients' CBC weekly during linezolid therapy; discontinuation of therapy may be required in patients who develop or have worsening myelosuppression; use with caution in patients with pre-existing myelosuppression.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     <i>",
"      C. difficile",
"     </i>",
"     -associated colitis has been reported; fluid and electrolyte management, protein supplementation, antibiotic treatment, and surgical evaluation may be indicated. Peripheral and optic neuropathy with vision loss have been reported primarily in patients treated for longer than 28 days with linezolid. Cases of lactic acidosis in which patients experienced repeated episodes of nausea and vomiting, acidosis, and low bicarbonate levels have been reported; patients experiencing these symptoms should be evaluated immediately. Linezolid should not be used in the empiric treatment of catheter-related bloodstream infections (CRBSI) but may be appropriate for targeted therapy (eg, patient with CRBSI due to vancomycin-resistant enterococci) (Mermel, 2009).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     The manufacturer does not recommend the use of linezolid for empiric treatment of pediatric CNS infections since therapeutic linezolid concentrations are not consistently achieved or maintained in the CSF of patients with ventriculoperitoneal shunts. However, limited data in the form of case reports in pediatric and adult patients suggest that linezolid may be useful in treating gram-positive CNS infections that have failed to respond to other treatment options (Cook, 2005; da Silva, 2007; Milstone, 2007; Shaikh, 2001; Villani, 2002).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Oral suspension contains sodium benzoate; benzoic acid (benzoate) is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse; use caution when administering oral suspension containing sodium benzoate to neonates;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate displaces bilirubin from protein binding sites.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299606\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Inhibits",
"     </b>",
"     Monoamine Oxidase",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F188936\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Agonists (Direct-Acting): MAO Inhibitors may enhance the vasopressor effect of Alpha-/Beta-Agonists (Direct-Acting). Primarily with oral administration of phenylephrine.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dipivefrin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Agonists (Indirect-Acting): MAO Inhibitors may enhance the hypertensive effect of Alpha-/Beta-Agonists (Indirect-Acting).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Agonists: MAO Inhibitors may enhance the hypertensive effect of Alpha1-Agonists.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha2-Agonists (Ophthalmic): MAO Inhibitors may enhance the hypertensive effect of Alpha2-Agonists (Ophthalmic).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Altretamine: May enhance the orthostatic hypotensive effect of MAO Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: MAO Inhibitors may enhance the hypertensive effect of Amphetamines.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anilidopiperidine Opioids: May enhance the serotonergic effect of MAO Inhibitors. This could result in serotonin syndrome. Management: Avoid use of fentanyl (and other anilidopiperidine opioids when possible) in patients who have used a monoamine oxidase inhibitor within the past 14 days due to reports of unpredictable but severe adverse effects.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidepressants (Serotonin Reuptake Inhibitor/Antagonist): MAO Inhibitors may enhance the adverse/toxic effect of Antidepressants (Serotonin Reuptake Inhibitor/Antagonist).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antihypertensives: MAO Inhibitors may enhance the hypotensive effect of Antihypertensives. MAO Inhibitors may enhance the orthostatic hypotensive effect of Antihypertensives.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotics: May enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: MAO Inhibitors may enhance the neurotoxic (central) effect of AtoMOXetine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta2-Agonists: MAO Inhibitors may enhance the adverse/toxic effect of Beta2-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bezafibrate: MAO Inhibitors may enhance the adverse/toxic effect of Bezafibrate.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: May enhance the adverse/toxic effect of MAO Inhibitors.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BuPROPion: MAO Inhibitors may enhance the neurotoxic (central) effect of BuPROPion.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BusPIRone: May enhance the adverse/toxic effect of MAO Inhibitors. Specifically, blood pressure elevations been reported.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May enhance the adverse/toxic effect of MAO Inhibitors. Management: Avoid concurrent use of carbamazepine during, or within 14 days of discontinuing, treatment with a monoamine oxidase inhibitor.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for agranulocytosis may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     COMT Inhibitors: May enhance the adverse/toxic effect of MAO Inhibitors.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyclobenzaprine: May enhance the serotonergic effect of MAO Inhibitors. This could result in serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dexmethylphenidate: MAO Inhibitors may enhance the hypertensive effect of Dexmethylphenidate.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dextromethorphan: MAO Inhibitors may enhance the serotonergic effect of Dextromethorphan. This may cause serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diethylpropion: MAO Inhibitors may enhance the hypertensive effect of Diethylpropion.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Doxapram: MAO Inhibitors may enhance the hypertensive effect of Doxapram.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HYDROmorphone: MAO Inhibitors may enhance the adverse/toxic effect of HYDROmorphone.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypoglycemic Agents: MAO Inhibitors may enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Levodopa: May enhance the adverse/toxic effect of MAO Inhibitors. Of particular concern is the development of hypertensive reactions when levodopa is used with nonselective MAOI.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: MAO Inhibitors may enhance the adverse/toxic effect of Lithium.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the adverse/toxic effect of Linezolid.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Maprotiline: May enhance the adverse/toxic effect of MAO Inhibitors.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Meperidine: MAO Inhibitors may enhance the serotonergic effect of Meperidine. This may cause serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methadone: MAO Inhibitors may enhance the adverse/toxic effect of Methadone.  Management: Initial safety testing, where small incremental doses of methadone are given with the patient closely monitored (including vitals, etc.), is recommended if methadone is to be used with (or within 14 days of) an MAO inhibitor. Avoid transdermal selegiline.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methyldopa: MAO Inhibitors may enhance the adverse/toxic effect of Methyldopa.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylene Blue: MAO Inhibitors may enhance the serotonergic effect of Methylene Blue. This could result in serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: MAO Inhibitors may enhance the hypertensive effect of Methylphenidate.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: Serotonin Modulators may enhance the adverse/toxic effect of Metoclopramide. This may be manifest as symptoms consistent with serotonin syndrome or neuroleptic malignant syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: Linezolid may enhance the serotonergic effect of Mirtazapine. This could result in serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Orthostatic Hypotension Producing Agents: MAO Inhibitors may enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oxymorphone: May enhance the adverse/toxic effect of MAO Inhibitors.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pizotifen: MAO Inhibitors may enhance the anticholinergic effect of Pizotifen.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Reserpine: MAO Inhibitors may enhance the adverse/toxic effect of Reserpine. Existing MAOI therapy can result in paradoxical effects of added reserpine (e.g., excitation, hypertension).  Management: Monoamine oxidase inhibitors (MAOIs) should be avoided or used with great caution in patients who are also receiving reserpine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: MAO Inhibitors may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: Linezolid may enhance the serotonergic effect of Selective Serotonin Reuptake Inhibitors. This could result in serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin 5-HT1D Receptor Agonists: MAO Inhibitors may decrease the metabolism of Serotonin 5-HT1D Receptor Agonists.  Management: If MAO inhibitor therapy is required, naratriptan, eletriptan or frovatriptan may be a suitable 5-HT1D agonist to employ.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Eletriptan; Frovatriptan; Naratriptan.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin Modulators: May enhance the adverse/toxic effect of other Serotonin Modulators. The development of serotonin syndrome may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin/Norepinephrine Reuptake Inhibitors: MAO Inhibitors may enhance the serotonergic effect of Serotonin/Norepinephrine Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin/Norepinephrine Reuptake Inhibitors: Linezolid may enhance the serotonergic effect of Serotonin/Norepinephrine Reuptake Inhibitors. This could result in serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: Linezolid may enhance the hypertensive effect of Sympathomimetics.  Management: Reduce initial doses of sympathomimetic agents, and closely monitor for enhanced pressor response, in patients receiving linezolid.  Specific dose adjustment recommendations are not presently available.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tapentadol: May enhance the adverse/toxic effect of MAO Inhibitors.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetrabenazine: May enhance the adverse/toxic effect of MAO Inhibitors.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetrahydrozoline (Nasal): MAO Inhibitors may enhance the hypertensive effect of Tetrahydrozoline (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     TraMADol: May enhance the neuroexcitatory and/or seizure-potentiating effect of MAO Inhibitors. TraMADol may enhance the serotonergic effect of MAO Inhibitors. Management: Consider alternatives to combined treatment with tramadol and monoamine oxidase inhibitors due to an increased risk of serotonin syndrome and seizures. Avoid transdermal selegiline.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     TraZODone: Linezolid may enhance the serotonergic effect of TraZODone. This could result in serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: MAO Inhibitors may enhance the serotonergic effect of Tricyclic Antidepressants. This may cause serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: Linezolid may enhance the serotonergic effect of Tricyclic Antidepressants. This could result in serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tryptophan: May enhance the adverse/toxic effect of MAO Inhibitors.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1048297\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ingestion of tyramine-containing foods and/or beverages may cause hypertensive crisis; limit intake of tyramine-containing foods and/or beverages to less than 100 mg/meal",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F188938\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F188950\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse effects were observed in some animal reproduction studies at doses that were also maternally toxic. Information related to linezolid use during pregnancy is limited.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1048287\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC (weekly), particularly in patients at increased risk for bleeding, patients with pre-existing thrombocytopenia or myelosuppression, patients with chronic infection who have received or who are on concomitant antibiotics, or concomitant medications that decrease platelet count or function or produce bone marrow suppression, and inpatients requiring &gt;2 weeks of therapy; number and type of stools/day for diarrhea; visual function in patients requiring &ge;3 months of therapy or in patients reporting new visual symptoms",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1048278\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits bacterial protein synthesis by binding to bacterial 23S ribosomal RNA of the 50S subunit. This prevents the formation of a functional 70S initiation complex that is essential for the bacterial translation process. Linezolid is bacteriostatic against enterococci and staphylococci and bactericidal against most strains of streptococci.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1048293\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Well absorbed orally",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: Well-perfused tissues",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     V",
"     <sub>",
"      d",
"     </sub>",
"     :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Preterm neonates  &lt;1 week: 0.81 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Full-term neonates &lt;1 week: 0.78  L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Full-term neonates  &ge;1 week to &le;28 days: 0.66 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants &gt;28 days to &lt;3 months: 0.79 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants and Children 3 months to 11 years: 0.69 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adolescents: 0.61 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults: 0.65 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 31%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via oxidation of the morpholine ring, resulting in two inactive metabolites (aminoethoxyacetic acid, hydroxyethyl glycine); minimally metabolized; may be mediated by cytochrome P450",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 100%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Preterm neonates &lt;1 week: 5.6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Full-term neonates &lt;1 week: 3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Full-term neonates &ge;1 week to &le;28 days: 1.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants &gt;28 days to &lt;3 months: 1.8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants and Children 3 months to 11 years: 2.9 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adolescents: 4.1 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 4.9 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Oral: 1-2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Urine (~30% of total dose as parent drug, ~50% of total dose as metabolites); two metabolites of linezolid may accumulate in patients with severe renal impairment; feces (~9% of total dose as metabolites); Nonrenal clearance accounts for ~65% of the total clearance",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Clearance:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Preterm neonates  &lt;1 week: 2 mL/minute/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Full-term neonates &lt;1 week: 3.8 mL/minute/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Full-term neonates &ge;1 week to &le;28 days: 5.1 mL/minute/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants &gt;28 days to &lt;3 months: 5.4 mL/minute/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants and Children 3 months to 11 years: 3.8 mL/minute/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adolescents: 2.1 mL/minute/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults: 1.7 mL/minute/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dialysis: 30% removed in a 3-hour hemodialysis session (linezolid dose should be given after hemodialysis)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1048286\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?1/30/1510?source=see_link\">",
"      see \"Linezolid: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Complete entire course of therapy even if symptoms improve. Avoid pseudoephedrine and excessive amounts of tyramine-containing foods while taking linezolid: Red wine, aged cheese, smoked or pickled fish, beef or chicken liver, sauerkraut, soy sauce, dried sausage, fava or broad bean pods. Notify physician of changes in vision, persistent or worsening symptoms of infection, diarrhea, nausea, or vomiting; watery and bloody stools (with or without stomach cramps and fever) can develop as late as 2 or more months after the last dose of antibiotic.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Thoracic Society and Infectious Diseases Society of America, \"Guidelines for the Management of Adults With Hospital-Acquired, Ventilator-Associated, and Healthcare-Associated Pneumonia,\"",
"      <i>",
"       Am J Respir Crit Care Med",
"      </i>",
"      , 2005, 171(4):388-416.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ang JY, Lua JL, Turner DR, et al, \"Vancomycin-Resistant",
"      <i>",
"       Enterococcus faecium",
"      </i>",
"      Endocarditis in a Premature Infant Successfully Treated With Linezolid,\"",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 2003, 22(12):1101-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/14688576/pubmed\" id=\"14688576\" target=\"_blank\">",
"        14688576",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Aronoff GR, Bennett WM, Berns JS, et al,",
"      <i>",
"       Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children",
"      </i>",
"      , 5th ed. Philadelphia, PA: American College of Physicians; 2007, 167.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Baddour LM, Wilson WR, Bayer AS, et al, \"Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2005, 111(23):e394-434.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/15956145/pubmed\" id=\"15956145\" target=\"_blank\">",
"        15956145",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bradley JS, Byington CL, Shah SS, et al, &ldquo;The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America&rdquo;,",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2011, 53(7):617-30.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/21880587/pubmed\" id=\"21880587\" target=\"_blank\">",
"        21880587",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Brier ME, Stalker DJ, Aronoff GR, et al, \"Pharmacokinetics of Linezolid in Subjects With Renal Dysfunction,\"",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 2003, 47(9):2775-80.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/12936973/pubmed\" id=\"12936973\" target=\"_blank\">",
"        12936973",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Clemett D and Markham A, &ldquo;Linezolid,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 2000, 59(4):815-27.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/10804037/pubmed\" id=\"10804037\" target=\"_blank\">",
"        10804037",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Condos R, Hadgiangelis N, Leibert E, et al, \"Case Series Report of a Linezolid-Containing Regimen for Extensively Drug-Resistant Tuberculosis,\"",
"      <i>",
"       Chest",
"      </i>",
"      , 2008, 134(1):187-92.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/18628223/pubmed\" id=\"18628223\" target=\"_blank\">",
"        18628223",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cook AM, Ramsey CN, Martin CA, et al, &ldquo;Linezolid for the Treatment of a Heteroresistant",
"      <i>",
"       Staphylococcus aureus",
"      </i>",
"      Shunt Infection,&rdquo;",
"      <i>",
"       Pediatr Neurosurg",
"      </i>",
"      , 2005, 41(2):102-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/15942282/pubmed\" id=\"15942282\" target=\"_blank\">",
"        15942282",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      da Silva PS, Monteiro Neto H, and Sejas LM, &ldquo;Successful Treatment of Vancomycin-Resistant Enterococcus Ventriculitis in a Child,&rdquo;",
"      <i>",
"       Braz J Infect Dis",
"      </i>",
"      , 2007, 11(2):297-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/17625782/pubmed\" id=\"17625782\" target=\"_blank\">",
"        17625782",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dauby N, Muylle I, Mouchet F, et al, \"Meropenem/Clavulanate and Linezolid Treatment for Extensively Drug-Resistant Tuberculosis,\"",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 2011, 30(9):812-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/21378593/pubmed\" id=\"21378593\" target=\"_blank\">",
"        21378593",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dotis J, Iosifidis E, Ioannidou M, et al, \"Use of Linezolid in Pediatrics: A Critical Review,\"",
"      <i>",
"       Int J Infect Dis",
"      </i>",
"      , 2010, 14(8):e638-48.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/20106697/pubmed\" id=\"20106697\" target=\"_blank\">",
"        20106697",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Heintz BH, Matzke GR, Dager WE, &ldquo;Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 2009, 29(5):562-77.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/19397464/pubmed\" id=\"19397464\" target=\"_blank\">",
"        19397464",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jungbluth GL, Welshman IR, and Hopkins NK, \"Linezolid Pharmacokinetics in Pediatric Patients: An Overview,\"",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 2003, 22(9 Suppl):153-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/14520140/pubmed\" id=\"14520140\" target=\"_blank\">",
"        14520140",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kearns GL, Abdel-Rahman SM, Blumer JL, et al, &ldquo;Single Dose Pharmacokinetics of Linezolid in Infants and Children,&rdquo;",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 2000, 19(12):1178-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/11144380/pubmed\" id=\"11144380\" target=\"_blank\">",
"        11144380",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kearns GL, Jungbluth GL, Abdel-Rahman SM, et al, &ldquo;Impact of Ontogeny on Linezolid Disposition in Neonates and Infants,&rdquo;",
"      <i>",
"       Clin Pharmacol Ther",
"      </i>",
"      , 2003, 74(5):413-22.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/14586382/pubmed\" id=\"14586382\" target=\"_blank\">",
"        14586382",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kumar S, Kohlhoff S, Valencia G, et al, \"Treatment of Vancomycin-Resistant",
"      <i>",
"       Enterococcus faecium",
"      </i>",
"      Ventriculitis in a Neonate,\"",
"      <i>",
"       Int J Antimicrob Agents",
"      </i>",
"      , 2007, 29(6):740-1.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/17395431/pubmed\" id=\"17395431\" target=\"_blank\">",
"        17395431",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lipsky BA, Berendt AR, Deery HG, et al, \"Diagnosis and Treatment of Diabetic Foot Infections,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2004, 39(7):885-910.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/15472838/pubmed\" id=\"15472838\" target=\"_blank\">",
"        15472838",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Liu C, Bayer A, Cosgrove SE, et al, \"Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant",
"      <i>",
"       Staphylococcus aureus",
"      </i>",
"      Infections in Adults and Children: Executive Summary,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2011, 52(3):285-92.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/21217178/pubmed\" id=\"21217178\" target=\"_blank\">",
"        21217178",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mermel LA, Allon M, Bouza E, et al, \"Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2009, 49(1):1-45.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/19489710/pubmed\" id=\"19489710\" target=\"_blank\">",
"        19489710",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Meyer B, Kornek GV, Nikfardjam M, et al, \"Multiple-Dose Pharmacokinetics of Linezolid During Continuous Venovenous Haemofiltration,\"",
"      <i>",
"       J Antimicrob Chemother",
"      </i>",
"      , 2005, 56(1):172-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/15905303/pubmed\" id=\"15905303\" target=\"_blank\">",
"        15905303",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Milstone AM, Dick J, Carcon B, et al, &ldquo;Cerebrospinal Fluid Penetration and Bacteriostatic Activity of Linezolid Against",
"      <i>",
"       Enterococcus faecalis",
"      </i>",
"      in a Child With a Ventriculoperitoneal Shunt Infection,&rdquo;",
"      <i>",
"       Pediatr Neurosurg",
"      </i>",
"      , 2007, 43(5):406-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/17786008/pubmed\" id=\"17786008\" target=\"_blank\">",
"        17786008",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Park IN, Hong SB, Oh YM, et al, \"Efficacy and Tolerability of Daily-Half Dose Linezolid in Patients With Intractable Multidrug-Resistant Tuberculosis,\"",
"      <i>",
"       J Antimicrob Chemother",
"      </i>",
"      , 2006, 58(3):701-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/16857689/pubmed\" id=\"16857689\" target=\"_blank\">",
"        16857689",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pinon M, Scolfaro C, Bignamini E, et al, \"Two pediatric Cases of Multidrug-Resistant Tuberculosis Treated With Linezolid and Moxifloxacin,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2010, 126(5):e1253-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/20974784/pubmed\" id=\"20974784\" target=\"_blank\">",
"        20974784",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      <i>",
"       Red Book: 2012 Report of the Committee on Infectious Diseases",
"      </i>",
"      , \"Antibacterial Drugs Dosage Tables,\" 29th ed, Pickering LK, ed, Elk Grove Village, IL: American Academy of Pediatrics, 2012, 808-16.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schaaf HS, Willemse M, and Donald PR, \"Long-Term Linezolid Treatment in a Young Child With Extensively Drug-Resistant Tuberculosis,\"",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 2009, 28(8):748-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/19633523/pubmed\" id=\"19633523\" target=\"_blank\">",
"        19633523",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schecter GF, Scott C, True L, et al, \"Linezolid in the Teatment of Multidrug-Resistant Tuberculosis,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2010, 50(1):49-55.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/19947856/pubmed\" id=\"19947856\" target=\"_blank\">",
"        19947856",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shaikh ZH, Peloquin CA, and Ericsson CD, &ldquo;Successful Treatment of Vancomycin-Resistant",
"      <i>",
"       Enterococcus faecium",
"      </i>",
"      Meningitis With Linezolid: Case Report and Literature Review,&rdquo;",
"      <i>",
"       Scand J Infect Dis",
"      </i>",
"      , 2001, 33(5):375-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/11440224/pubmed\" id=\"11440224\" target=\"_blank\">",
"        11440224",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stevens DL, Bisno AL, Chambers HF, et al, \"Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2005, 41(10):1373-406.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/16231249/pubmed\" id=\"16231249\" target=\"_blank\">",
"        16231249",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tan TQ, &ldquo;Update on the Use of Linezolid: A Pediatric Perspective,&rdquo;",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 2004, 23(10):955-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/15602197/pubmed\" id=\"15602197\" target=\"_blank\">",
"        15602197",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Taylor JJ, Wilson JW, and Estes LL, \"Linezolid and Serotonergic Drug Interactions: A Retrospective Survey,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2006, 43(2):180-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/16779744 /pubmed\" id=\"16779744 \" target=\"_blank\">",
"        16779744",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Trotman RL, Williamson JC, Shoemaker DM, et al, \"Antibiotic Dosing in Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2005, 41:1159-66.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/16163635/pubmed\" id=\"16163635\" target=\"_blank\">",
"        16163635",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tunkel AR, Hartman BJ, Kaplan SL, et al, \"Practice Guidelines for the Management of Bacterial Meningitis,\"",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2004, 39(9):1267-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/15494903/pubmed\" id=\"15494903\" target=\"_blank\">",
"        15494903",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Villani P, Regazzi MB, Marubbi F, et al, &ldquo;Cerebrospinal Fluid Linezolid Concentrations in Postneurosurgical Central Nervous System Infections,&rdquo;",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 2002, 46(3):936-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?21/52/22345/abstract-text/11850294/pubmed\" id=\"11850294\" target=\"_blank\">",
"        11850294",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12555 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-558F5CFEDC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_52_22345=[""].join("\n");
var outline_f21_52_22345=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188966\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188967\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048288\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11443849\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048281\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188942\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188927\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048291\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189000\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048284\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048290\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189002\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188999\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048294\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048280\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048279\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299606\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188936\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048297\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188938\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F188950\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048287\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048278\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048293\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1048286\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12555\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12555|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=related_link\">",
"      Linezolid: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?1/30/1510?source=related_link\">",
"      Linezolid: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f21_52_22346="HC in comm hydrocephalus";
var content_f21_52_22346=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F82118&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F82118&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 627px\">",
"   <div class=\"ttl\">",
"    Head circumference in a child with communicating hydrocephalus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 607px; height: 782px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Head circumference of a child with communicating hydrocephalus. A ventriculo-peritoneal shunt was placed at 6 months of age; it became nonfunctional at 15 months and was revised.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Developed by the National Center for Health Statistics in collaboration with the National Center for Chronic Disease Prevention and Health Promotion (2000). file://www.cdc.gov/growthcarts.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_52_22346=[""].join("\n");
var outline_f21_52_22346=null;
var title_f21_52_22347="Quantitative drug levels";
var content_f21_52_22347=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F63521&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F63521&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Quantitative drug levels that may direct therapy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Acetaminophen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carboxyhemoglobin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methemoglobin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Digoxin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lithium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Theophylline",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Salicylate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Paraquat",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Iron",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methanol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ethylene glycol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Antiepileptic agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Carbamazepine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Phenytoin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Valproic acid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Heavy metals",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Lead",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Mercury",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_52_22347=[""].join("\n");
var outline_f21_52_22347=null;
var title_f21_52_22348="Protein intake CKD children";
var content_f21_52_22348=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F81506&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F81506&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommended dietary protein intake in children with chronic kidney disease*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Age",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"5\">",
"        Dietary reference intake&nbsp;(DRI)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        DRI (g/kg/day)",
"       </td>",
"       <td class=\"subtitle2\">",
"        Recommended for CKD stage 3 (g/kg/day) (100 to 140 percent DRI)",
"       </td>",
"       <td class=\"subtitle2\">",
"        Recommended for CKD stages 4-5 (g/kg/day) (100 to 120 percent DRI)",
"       </td>",
"       <td class=\"subtitle2\">",
"        Recommended for HD (g/kg/day)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle2\">",
"        Recommended for PD (g/kg/day)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        0 to 6 months",
"       </td>",
"       <td>",
"        1.5",
"       </td>",
"       <td>",
"        1.5-2.1",
"       </td>",
"       <td>",
"        1.5-1.8",
"       </td>",
"       <td>",
"        1.6",
"       </td>",
"       <td>",
"        1.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        7 to 12 months",
"       </td>",
"       <td>",
"        1.2",
"       </td>",
"       <td>",
"        1.2-1.7",
"       </td>",
"       <td>",
"        1.2-1.5",
"       </td>",
"       <td>",
"        1.3",
"       </td>",
"       <td>",
"        1.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1 to 3 years",
"       </td>",
"       <td>",
"        1.05",
"       </td>",
"       <td>",
"        1.05-1.5",
"       </td>",
"       <td>",
"        1.05-1.25",
"       </td>",
"       <td>",
"        1.15",
"       </td>",
"       <td>",
"        1.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        4 to 13 years",
"       </td>",
"       <td>",
"        0.95",
"       </td>",
"       <td>",
"        0.95-1.35",
"       </td>",
"       <td>",
"        0.95-1.15",
"       </td>",
"       <td>",
"        1.05",
"       </td>",
"       <td>",
"        1.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        14 to 18 years",
"       </td>",
"       <td>",
"        0.85",
"       </td>",
"       <td>",
"        0.85-1.2",
"       </td>",
"       <td>",
"        0.85-1.05",
"       </td>",
"       <td>",
"        0.95",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     &nbsp;",
"    </p>",
"    <div class=\"footnotes\">",
"     CKD: chronic kidney disease; HD: hemodialysis; PD: peritoneal dialysis.",
"     <br>",
"      * Children with chronic kidney disease stages 3 to 5 and 5D.",
"      <br>",
"       &bull;&nbsp;DRI + 0.1 g/kg/day to compensate for dialytic losses.",
"       <br>",
"        &Delta;&nbsp;DRI + 0.15-0.3 g/kg/day depending on patient age to compensate for peritoneal losses.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: National Kidney Foundation. KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis 2009; 53:S11. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_52_22348=[""].join("\n");
var outline_f21_52_22348=null;
var title_f21_52_22349="Summary ACIP recs III";
var content_f21_52_22349=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F63112&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F63112&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Summary of ACIP recommendations on non-routine immunization of immunocompromised persons",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Vaccine",
"       </td>",
"       <td class=\"subtitle1\">",
"        Routine (not immuno- compromised)",
"       </td>",
"       <td class=\"subtitle1\">",
"        HIV infection/ AIDS",
"       </td>",
"       <td class=\"subtitle1\">",
"        Severely immuno- compromised (non-HIV related)*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Post-solid organ transplant or chronic immuno- suppressive therapy",
"       </td>",
"       <td class=\"subtitle1\">",
"        Asplenia, renal diabetes, Asplenia, renal failure alcoholism, and alcoholic cirrhosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\">",
"        Live vaccines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        BCG",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        OPV",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Vaccinia",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Typhoid, Ty21a",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Yellow fever",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Influenza",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Contraindicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\">",
"        Killed or inactivated vaccines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        eIPV",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cholera",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Plague",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Typhoid, inactivated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Rabies",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Anthrax",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"       <td>",
"        Use if indicated",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Severe immunosuppression can be the result of congenital immunodeficiency, HIV infection, leukemia, lymphoma, aplastic anemia, generalized malignancy, or therapy with alkylating agents, antimetabolites, radiation, or large amounts of corticosteroids.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Yellow fever vaccine should be considered for patients when exposure to yellow fever cannot be avoided.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: CDC. Recommendations of the advisory committee on immunization practices (ACIP): use of vaccines and immune globulins for persons with altered immune competence. MMWR 2006; 55RR-15:1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_52_22349=[""].join("\n");
var outline_f21_52_22349=null;
var title_f21_52_22350="Lung volumes by state";
var content_f21_52_22350=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F64766&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F64766&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lung volume subdivisions in various conditions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 421px; height: 280px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal persons have an FRC/TLC ratio of about 50 percent and an RV/TLC ratio of 20 to 30 percent. Patients with restrictive pulmonary disorders (first column) can be expected to have reductions in FRC, TLC, and RV, whereas patients with neuromuscular weakness (fourth column) have an elevated RV, reduced TLC, and normal FRC. Asthma (third column) is characterized by elevations in RV, FRC, and in more severe cases, TLC.",
"    <div class=\"footnotes\">",
"     VC: vital capacity; VT: tidal volume; ERV: expiratory reserve volume; RV: residual volume; TLC: total lung capacity; FRC: functional residual capacity.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_52_22350=[""].join("\n");
var outline_f21_52_22350=null;
var title_f21_52_22351="M-mode echocardiogram of AR";
var content_f21_52_22351=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/66664/aormmdec_conv.mp4?title=M-mode+echocardiogram+of+AR\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    M-mode echocardiogram of aortic regurgitation in a patient with bicupsid aortic valve",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 318px; height: 240px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADwAT4DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDyqiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooqS1gmu5mitYZZ5VQyMsaliFHU4HYetAEdFNDAqGHQ0ufcUALRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFACGtHQls1vh/aESTxupRbd0ysrEcANg7Wzjna30rKuJBFDvKkluEHTc3pU1l4rl0hfs81pbpcRvy0ysHT1BxjHHSgCxbR21h4ntY9Xg3WdrPtu4gjHIHVSpAJ+mPwr0j4x6p4au/CNpBpH2WbWt6C3ktV5hgB5UkcAH+4eRnoK838SavaSv9rbTLuzS8PnRyzoSZAOCQxA3DIPIHFU0ZZVV0bchGRQAq52jPXHNOoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACnwp5j4zhQMsfQetFvDLcTJDbxSSyucKkalmY+wHWszxLdvp9o9muRPOMOO6gHBB9O9AGLrOsyy3sgspnit1+VdjFd49TjrW07HxNZW9jZ6I3/CQDktbLhZI1HHyY+9jknPPpXE9T2q7Z3ctvcRMkrqFP8P8AhnmgDXSFZdNt38mxhWJzEzifEsp6/MjSZwMdQoHPNWdHvQJfs7kgnlO+a0rfTY7/AEK6v7LR5pLbzMG+vmW3iTHJCNuVNxz907ye1ZcN/pS2kYhsoo7tASXeUvk+wI4+me9AG0OaWq9ldfaot5K7hwQoxzVigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACivV/wDhXNr/AMKk/tHzYP8AhKfK/tj7P5o8z7B937u/G3H7zdjOfk61IvwYl/teysG1tA73hsLpxbEiKb7ILkeX837xMZXJ2HPY0AeSUV6P4L8OeFNRv/FML319qNrYaPcXUNwbPycOhwZVUTZbA2lVbG7cd23aMyWngC21PwtoepQ3iQWz6df6jeTC1Yz7bdlVlCmUo53NhceX8vJyeKAPNKK1PE+knQtevNOMrzCBgFkkt5IGZSAVJjkAZTgjgj6EjBOXQAUV7H4j+FMUHhbQodMntT4khnht9YjMwJha5YCIyAO20ISE+VfmB3dqp/8ACo4Evn8/xF5OmR2t9PJdNYkuhtJxFKDGHOV53AhiT02igDyiiu/0PQfDd34D8a6kJb64uNO+y/ZJ5bcRsm9sfcWUqdzZU5ztUBhknaNi7+GlnOtrdRah9m0waZYXDSW9hJJPK91K0aEw+a2W4y2xvQKhoA8ooqxqFq9jqF1aSnMlvK0THay8qSDwwDDp0IB9QDVegAooooAKKKfDE00ionU/pQBLpF+dJ17TdRVY3e1nWRVkztz6nBB4znrR8b9CvofE9zrdw4e11NvNgmkYbp+BllUfw84rlNZ1YtqwNo5EUPyoytjd6nNd54H8T2N3pTeGfFsLXmhyAyQyoP31jJ/z0j4zjOMrnBxQB5E0ZA3bTszjcBx+daR0bURbiYWc/kkA7whxz07V3WvfDHVrVEv9FSPX9DdiVu9PBcADtMoGYz+nPWuR8R6LrPh8xQ6hb3Vrb3A8yIFiUkHcgjg0AbnhXXbqy1K0sNWsor2CNTHDbajKEihZv4gJg0Qz3LqfbBwa5qVGutSuJI7ZU+ckx23zRrz0BBxj6Gmw6oXFrHfQrcxW75WN+MqeqlhhsfQjFdbN4huNNL2Xh5bK3spEVpUsQ7KWPOC0g3kjJ7kA9DQBzljcSWWo7pI2iik4dcHCn2rpgQRkYI9jWPJaRXMrTXMpWYnJ5zu+uOf1pdKukW5e0VywXlWOAWHX1oA2KKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDQ/tvVf+gnff8AHr9i/wCPh/8Aj3/549f9X/s9PapF8Q60r2Trq+oh7FSlqwuXzbqVCkR8/KCABgY4GK0/hn4gtfC3jfTdZ1COeS1tvN3rAoLndE6DAJA6sO9dJ4H+JLWOq6lfeKJ9Rury6a3ZL2Ha8sSRziV4FBZQscgyCFIA4+UjoAeeWF7daddx3Wn3M9rdR52TQSFHXIIOGHI4JH41sX7eJPDv9i/aLy+s/wDRftmneXdH93FNnLJtb5N2DkcE9xXZ/wDCxdFPhDU9NTRpLZ7lb5FsolQ2zNPKjxSsePnhClV+Q8BcFeg5vx/4t/4Sy08OtJNfG6sLFbS4jnbejSKeZlbdks4xuyoI2jluoBtNbnKXE8tzcSz3MrzTysXkkkYszsTkkk8kk85qOiigRfudb1W6+2fadTvpvtuz7V5lw7efs+5vyfm29s5x2qx/beuajf5l1m+kurmL7E0s96w3RMeY3dmwI8nJBO3ua6jwl8QP7D8Falpclv5uppu/si8KbmsvNG2fa+4NH8vK7B94knNSSeLtB/4VVL4cS11FtQZYWQzt5sUUyzMzuhL4QMjEYSNTyQzPnNAHKanaaz4T1a+0y6afT77yvIuY4px80bqG2MUOGUgrkZIqO38Q61bXEU9tq+owzxQC1jkjuXVkhByIwQchAedvSvT2+LNgvi/xLqP9nyXen3axXWnQXkCyG3voolRJCu/Cg4OWU7sBcYxWHB8QoE+HE2iPa+Zqc/2hbmW4iMyXZldW85m8xcSrjhmSQ/IuCuSKBtWdmecUUUUCCiiigAou479tGvJdLt5JXXCTSIP9Upz39Tg/rRV6x1fUbCwnsrG+urezn5lgilZEf6qDg/jQB5Y24Eq2QR2PatrRtQitZFN5bC4t9hGEkKMM9DkZHB9RXQ3Gn2c8JR7eMHsyKFYfiP65rJk0B4JkeymU4JbEuRj0wV6/pQB2nw+8fL4Z1I3UMt6kWBm2NwV3Ej2U9PbFeoSfErwhqyG113w9DLYeaLny4nC7pO7OFRA2ffNeAv50cEQurGWRxyvlupz65wCfzNOW3lmhPkmWFAeEbKn9e1AGjeTaB59zJY6UsSTO3liR2/dAnjGD0Hoc10Wj+H9a1SOOK5vrTSLQWpIZ7UKUTrksqZLHPByWrkl8PSKBPFcRSkDJjdkXP/fRwfyrrm1G9i8PvaC7sEkhVCVhyJJzjG3zAucDuNyj60AZ+seE7LTY/tGo6ub9yuI0VWAH/XTcQ6eo4Oa4bUbiNJYktokjaLo6Pkk+5xXRulxPbpBMypChJVI84yf8+lPhtLaLaViBIwQWHOfrQBMILqGOL7ZBJBI6BtrrgkHoR7Glq3rGpX2tPE+sXdxftEu1DcytKUHoNxOKqUAFFFFABRRRQAUUUUAFFFFABRRRQAVDd3AtYfMKb/mCgZxyTU1ZuvEiwznAEinP4igDr18HeIp0R9O0+G+BGW8m5C+X6A7wvPXpmhvA/jEdfDpGP+n2D/4qvYfhyS2nXGTlikR56nj/AOvXWTfePGaAPnD/AIQzxd/0L7f+BcX+NIfBvi3toBH/AG9xf/FV9COSCKrXc8VrbzTzOUhiQu7YzhQMk4FDdhpOTstzwJPCfiedN1vohkQEoW+1RDDKSGHJ7MCPwp3/AAh3i3/oAH/wLi/+Kr3LQ4ZLXRNPgnXbNFbxo65BwwUAjirmTUwVoq5timnWm47XdvTp8rbHgH/CG+Lsf8gE/wDgXF/8VQfBvi3P/ICP/gXF/wDFV78CM/SlJ/XpVGB4D/wh3i3H/IAP/gXF/wDFUyTwp4ngAe40UxpuCg/aojlmICjg92IH419Afr6is27/AH+t2MOfkgSS5JXqrY2KD6Ah5PqV9jUT+G3c6MKl7VSey1+7W3z2PFP+EO8WnP8AxITn/r7i/wDiqQ+DfFv/AEAiMf8AT3F/8VXvmaAfr7VZg227s8E/4Q3xb/0AD/4Fxf8AxVB8HeLD00A/+BkX/wAVXvgbOOufeolmjkkZUdWZPvYPSgR4QPB3izJ/4kH/AJNxf/FUf8Id4sz/AMgE4/6/Iv8A4qveyf8A9VBHvz60AeB/8Id4t/6AX/k3F/8AFUo8HeLO+gn/AMDIv/iq98pB1x3HpQB4H/wh3izP/IB/8m4v/iqP+EN8W4/5AP8A5Nxf/FV76eg7CkGc+9AHgf8Awh3i3P8AyAef+vuL/wCKpT4O8Wkf8gE/X7XF/wDFV73ngf5xRknHc0AeCf8ACH+Lf+gCfT/j7i/+KpP+EO8W4x/YP/k3F/8AFV73njilzjrxQB4H/wAId4tz/wAgEn63cX/xVH/CHeLf+gEf/AuL/wCKr3zt14oPJzjmgDwVfBni522poBZjwB9sh/8AiqxvEcFz4ehspNREGLkkbYpCzRkdQ2VAz9Ca+mLTi8hJJ+8OlfPXxxj/AHFq3G5Ly4Rgo+UHdnigDKooooAKKKKACiiigAooooAKKKKACs3xBzpj4/vL/wChCtKs/XATYADvIg/WgD1i61vUNF0mxj0oIHuUVpnYOSoXBAXZzz3zTT8R/EQyDbafn3gm/wDiql1O3nm0+1FknzRxruxxxjAA7f8A6qyYdOvpJ/8ASA6J7MCT9OKAJm8da+dRuLrZa/vQB5PlzeWmP7q54zSX3jvWrvTbqzmt7AR3CeU7rDLuUE87STwccVHfWot9xia4lwANium7P4gDH41FFAkkNrFIJIpJpPnaQr+7AyR0JHOPf3xxUVPhaOjCaVoy7O/yWr/BFuLx7r0MQUQ2blQAC8UpJ9zzVy78UaqdMGvFoEuTtg+zLG4gYf39obdu7Z6VkFpI55PKtZv3Z+QtIhD/APj1adi0twJndGVY13JE+0lz3VSCcH64qznJE8aeJ/s8rJZ6WQ8bIGaOTK5GNw+bgiq1j4i1TTrRokuTfakqqzvcBnjK85xsP3unU1kzDXZCw+zyRDJwqOgIHoTxmkS31gOjG0nIB5+deR+dAGhe+ONfmubVmjs4DbFgUjjmUSZ/vjPOO1La+OtahvJLoW1hLI4VW3wykbVzhRg9Msx55yT2wBFNuty1xJbXR25YxyMm0/Xk9KihimjsPJNo7S9SWnjwx/Bh/Woeskjoh7lGUu9l+r+6y+8nsfG2vWiMpFtMWdnzKkrYz2HPQdhT73x1r1zBDF5dnB5cgk3RRyqzY/hJzyvtUMgmks/Lks5d4GFC3EZ2564JYfrTr2OdJ4Fgt2mjRF3bp0QA9wBk5/SrOcsH4ha8i5+z6aWGOsMuP/Qqs3viDVrMRalaRQvd6sxmuI2R2RCBwI1ByB1znvVeKCG4mhjkjktlz80jNHgfXDMSPoKks5bho0lvQ4jicoyQyqZJB2I5xj6kH2oAq3fjPxJqGn3NlFFaWrsVLTxRyRyIAc/KzHv0PBrVfxfq0Ok+ZALSeaMKG3o/T3AbOevNcrc/2zLNIUUhWclMFAcZ4BwfSnwW2tyTKNquG+8pnjUEfXdxQBoy+O9efU5LopZrvRY/JWOURrjuFz1Pc1LJ8QNcaCaPyLBTIhTesMoZc9wc8Gmto7vIzfbjDFjIV+Sfx+vtTNOtwnMkUqtjrNKjdfZWxQA618d65BBHEY7OXYu3fJFKWb3JzyaSfx1rst5bXGyzjEEZTy0jlCSZ/iYZ5I7Gp5NPhih5fzXRScJKMuew7D+VVIVkWW3Bs5DEqnczSRZB9wGO6gCpY/F3U31K+tvI0v8A0Qbizxy4YDhieeNp45p0fxG/srQre6S/S4u5ZALkXiSHywV3JtXhsMDkE5BHQ1mJ4G0y3ARVLLZpKkbpIge7WQEEO2AeMkD7vFFp4Qhj0v7a4vJNQt54ZIYGmjbzfKULGGK8BVGc4wTz7UAXNU+I+vXuoaFZxxR2/mSO+6GCaPzMdnB5ZeOgxgcng1eT4mFIZbiSdPt9tLLHFDJDMyPt+ZvMTaGUhc5HIX1rP1Syu9Rk0uf7FJDe2Rc74pEwdwwVwc5BHfr6YrH/AOEVvBcNcRx30Vw00s/mxzxhlMq7XAOOMj8R60AdRZePNej86ZBZTxTt5qlklZVB6BeeFqe/8c+ILqyFs0FrbFnWUSxQzI5A7A5+6agg85NOSB7GZZVYBT5ykbAO7Fsk/Wpfts/lEfYH3NwQJYwAPUHNAEqfELXoSJFg04spBG6GXH/oVc78Wv8ASfCeh3k523V9dyyyovCqT/dB5x9a2/OZYlKWcolxyN0QH57v6Vg/F8H/AIRzw0chAZJfl5+XkUAZFFFFABRRRQAUUUUAFFFFABRRRQAVQ1s4sgcZ/ep/Or9UNa/480/66p/OgD1jVPMWGzCC3bdENwmYKBwPWsiVZ4iQRpJx3EgP8ga6qLTJdRWGSGRoxFEFOxsZJHfiq/8AwjV7JEUdwrf30iC4/PNAHMCWU4IGlkHuDx/KkZp/tSApYZCnopK8kdfl69cfjXXSeHwHX7QZZc9CjkH+fNUE8Ob7u+2LL+5ZYlJdlIONx444w6/r+MT6L+u504fTnn2T/H3f1MKSSWNvmTTg3+4f/ians7hWt7iKeewhLYKc7EJ/2sgV0cXhtFkYzTHceuZS36mo9W8Nwx248l3DZG3Knp34qzmOZCB5ton0nnv5hx09elPZOpkudNJH/TTJ/nWhJpN5DE829Vto1+dpM7V9zn+pqwlpeeUn2eaGVCMq2Ay49sr/ACoA5y5YgoqyWBLMMlVLYxz6HjjH407z7rg/6Aw9VgJ/9krftdDuZNRnb5soihiCSNzckdsEAKcejA9xWi/hiVlUgs57jzCR/M1EdW2dFf3Ywp+V36vX8rHI+bdnotp/4Df/AGFDS3g6pag+9sf/AIiuvm8NSbDGI1Ct0djkj16VG3hx9qjdsK9SWJ/QtirOc5Jrm4B5Fnz/ANMMf+yVdtZ2bQXkZogyS/wrhf5Dmulg0Nyn7x49h7M56fgTTb/R5ZTbLCWfy8n5CwUH1I9fzoA5BJ5JiBG8TDPHA/xqdjcqQHRGJ4weM/8Aj1aV7pM8FsrX0htrUOOZcKpc/d+Y5yeuKvQ6Cp8uaRGlIP8AC3I/MAHpQBzM88kTspEAI4PmIT/Q0xrq525UWWP+uP8A9hXUv4eea4MsMXlSE53/ADNg+3/1qk/4Ra4LjGJD3aRjzQBxv2i5/vWX/fv/AOwp6y3gb7tof+2Wf/ZK15X0tr+bT01OwiubfzBKrl0QGMBnVZG+RmUMCy7sr36HFeLVtKubBriK/tzEskcWGjlWZmkAMYWL77bgcjCnIBI6HAByusT+IF1eGC1EIs7jG5xaA+Rt5bny8DcOBuB59Kbbanq82uJp9zBt0yYyxSpcR/uQAgIYEKAAxyOWbOSCBxXYjU/DywWctxqluftaCVGj3lFQsEDOcHYNx2kvtAOR1Bwsl3o9/ez2VtqMhurcyp5QgkzI8X+sRPlw7AEHau4kc0AeaaWda07w9pS2DW8bzM9tJFMh3QlpGKyt8uQB6kkYI4rUkuNX/wCEoithLataqI/mcgpMu07yzqCFfI4+ZBwODmtTSPENpPpem3uozy2X26Ro4IzbyTsxRgpCELz1XoOpxyQav3VxZQahNHLqyWsMVoLyR5lmR9pIA+Ux4x8wGAS275duQcACkyGPIOnL7NLk/wBaYXmBIL6YD7kf/E0l9qVpY6fp81vJLdreX4sJNkUgkgbJDAjYWDjshAZgeM1p2cWizaxFYx3zSXL3E9oEZHZjLCoaRcsABgMOc4PYmgDLkkmKf6zTM9ju/wDsap/FsY8NeFQww2+TIH3e3SvQh4Ye4KxNLKik9VbB/PIrz741gRaV4dhUgrFJKp9c5H+FAGRRRRQAUUUUAFFFFABRRRQAUUUUAFUNa/48l/66p/Or9UNaP+hp/wBdU/nQB9F+FQn2V90ioSE4Jxn5a1ro5yQy/UbhWL4YkjS1kDsgbbGRlsH7tbcjq/yCRPcDmgCgFjPyo2CPbFVNGhjeG9uJ2QtLcyZ+YnGxvLGPwRf1+g0JopEj3JNH/wB+zn+dZWgySyaNZlpQWmjE7/us5d/nY+2SSah/EvmdMNKE2u8V8tX+aRe2xgMFjtn9zjP/AKDSj7ORyI+f7n/1hUzrKYlUliPQqAP1xULyCMBrkqqnuFP68VZzEE7RCKSTY3lou4kIzfkBkn6CkhnS4UEEhSAQHDJ+hXNWDcxmCW4Xa0cS7iVQlj9ABk/QDNcX4+1a9sxZPYXtzElwjhlMZjIxjn5gGB+b9B0rKtVVGDm+h3ZdgJ5hiY4am0nK++2iv0v2Og0ryZbRriSOOV7iV5QWJ+ZCcIQMcfIE/LnnNaeFKkAQRnsAP8KyfBtzf3WiefdWcUEXAgEXdOg+U5wPT1HYDBOot4xxiTd/vBQf6U6TUoJonMKcqWJnCVrp9HdLy+W3lsMP3GQPAUPVWAAP4c0kKCB/3UNoD6jp/KrUMryocPIR7Yz+hqtLJNvXKH8QT+mK0OMez7+ZHhB7YbP+FRzLbrw7RA9iCBT0M6nBBIPT5T/8TUrCYsSHKj0LY/XFAFG5kt7W3WfcxG4KPKy7ZP8AsqpOPfHFEeoW5O3ybksP+mf+NLftJb2yzNcMqbwgWJTM2T6qozj3xirUccka8v5o9SGU/jQA1ZFcBlWBPaQHNIcNy01sp9R/9el8wEgo3zfTj9amiaRlLAH2Ocf+ymgDko/BHh+LVNTu3EEn9oeaZY28tgrSLhykgXzVyN3AfA3NgDtGvgrSV0mGzm1fUJ2tpoJrWV7hS1uYVCoETb5YAGc5U5zk5OCOyuMRqOE+vmKP6VCk2cgSRKP+vhf8KAOUuPBfh2eawuru4aWayg8l5b2RLj7QgbefM81XGc7vmXaQGIBAwAaP4N0ePVIdYimulnS8ur1Y3kQAtOArZXYCFwoIGQRnnngbt8zXt2unrcIYtglnYHcCu75U7AhsMD14BB6g1deKfJBmWUHp8mfy61Kd35G04KEFf4nr6Lp9+/pbucrZ+FNB0O/0Ix3d8fsL3L2USgSJGsowyOypkAZJXc2eTyRirGu+D9I8Q3t1dahczs1xYjT3SN0UBBKJQw/2gwB6kccg1tXGYWt0maQPOT5ZS3ZgMdd2FIX8cfjTWa7KK0DAr/00iAP61RiUb7wnpt3YRW19qeoT3MV4L6K9nmV5UlByCAQUCgcbNu3HbPNYFt4Jjg8fxaxDLbwaZDLPdGDzvMaSaaNUYhdg2DIJ++44GAuTjumuUW1TLqJcDJGCCeOgFPScmIr58nuVjIx+lAEkEmm+YhYQY7jCmvD/AI5Q+VYaMhk3DzpsEdOvavaYgksyhbidSOcmQgf0rxr4/l/I0fcOksgBx16fnQBgqSVBIwaWiigAooooAKKKKACiiigAooooAKo6uM20anoZk/nV6qOrf6mD/rsn86APerHRbLVLcNfRRTeSAiLIM7Rjt9aW902XTJUvvDm5dp23OnvykydimeQ45PXFbXg8NJZTt8pjDKB1znFa11GI4yQzbh2OQf0oA4zxBrdrJol1E80UUk0TxIsx2EsykAc46Z5PQdTxT18Q6VnDalYKe2SmP0JrjfiVYsPEcDwW8+66iXkgsZJASuB742jA9vWu30Tw/pdjpkMV/D5tyFBklkG7LY52kjhew6fnXLSrOdWUbbHu47LqeGy+hWVS7nd2ta2iv1ezX/AL1tLDcw77YwXEYOPMiO4fmKiui8Mi+XaREH+LJAyPr9ap3ei2b3gudFu3sLtfvC3bYknHG4cg/lWf4ninSCGTXdZii+bajCPDL7fLjg/Suo8IdqutmwZE03Tn1HUHziFD+6j7ZkI6D26n2rKm8L65rNxZya7fQhCXd/lVBCOMIoBOc/U4x1z1u2WoSXLXCeHLRpraIZadslp29EBOMD1J79sVcg0HVZY0knySeWS5kJP0IGRUVKcakeWWx04TF1MHVVai7SV7fNNfroWbPw9JaQrHBezOI8bD5g28dselTW14qSrbXcaC55yzyBVY/wCycYPH5VvpAmBhJEbHZzj8qr3kazL5dxFEUPYg5qznbbd2QKI5U/16gH+7MCP5VWl06TeSqrJ6ETEf0plxoFrMuQZoz/0zbFZw037O5xPquAf45XwfwFAjROm3A2hbdTjuZM/0qT7DcSNiSFAe2GPP6Vkpqd1p115MTrek/egZS0sY6glScnNR6z4xgso1GpSrp8suMCZcNj1VQS5/AGgC7fah/Z8kMEMQu53Yr5EADGMcHc2cYHP1phk1GaM+fdW9oM8YO4/jjGPz71yEOqaprUrWvhu1ltbRm2+e2DMRjJPYIMe+a6HSPBt5E6ys6AqekkzsT9SKANNbLVjAGt7yKWRAx2KCPNPYLnofxqTTdR+3q4MQyDtaJvvow6gjHB4rYtfMiwkttGoH9wjFQ39hbTyNL5O2U/ekQYL+mSOTjJoAhfT0Vd7W6fkB/SsHUdf0q0vJbKddlwgX5TGMEnkDJwPTk4HPXrWu9o0fyxyXefUKa85utIute8QalKgdIIZDE8rncSVG3A6ZPGcds/TPNias4JKmrts9vJMDhcVOpLGy5acI3uu91bve+ui1O7062MNuhYCSdyXlZApBc9cHqQOg9AAKvRW0zkLFbYf/AH8H8hisbTpZNNgiigjeaCJQoDZMgHTnP+eKh1/xdBaxRW2qXB0pLkFWdW+eRe4Crlse+K3irJI8mvLnqSknfX0/Dp6D9R8QTrPLpWhQx3l/ysl0d3kW/rg8729gcDuT0qRPC9xNbKNd1O4vnBBPmJhMjoQowPSsLRNSu7vUWh0GykttIZdsbyriWUj+JiDhB6cN9fTuNN0++CA3TpGV7bi+76k1RkYmo+GYViFzp5uYL63XdbshIj3ejrwCD0p9trLqEt9R2294B8ySymME4ySpIGR9DXUywqrku4Huo/xqlcRadcRlL1IpPVZFDD9R9KAM6TVhGxPmWyKnJJu8gfjnFeTfHebz7Tw86ukglMj7kOQeR0I7V6//AGbozYj+xw7QeiRZH6V478eoltv7BigQwxxCRVj7L81AGRRRRQAUUUUAFFFFABRRRQAUUUUAFUdXO22iY9BMn86vVS1Vd8MKf3pkH60AfS/gyZVsphj5mKMM/wC7W1K/GWLH3Az/AErh9LN/bKX0+0SYYUFmHK4GPWtLT9emg1Q6drkQt7oqJI8cq647HJz+FAFrUNKgvtW069nBP2LzCkZTIZm24JyO2M/XBzxzpgZJKgKB6irSmN1BDLtPpimNtViRsOenrSUUm2uppOtOcYwk9Iqy8ldv82zNv7MyoTjzB6EDj6DofxrnNd8IWmuXFrLfW1wWhUou2RUBBOeQvWuwCgMAEx702U4Ukhio7k8CmZmdZ2q6VZeTYW8W6NT5at8qsfRmGcdeuDV62luHjH2qKOOXAzscuAfqQM/lVLVtQa0iMNjA1xeyoxgCJuRSOpcgjj2yDXEXnj+K1eOISXGrX5G2SDTIsxI3oXJIz7BjjoeaAPR9zA+oFJsDrhmPP0rg7X4laYZ1trq3vLG537HjuosBD2ywJUD8a9CgRXjV1ZHBGQUO4H8aAM17S6kk3G4x/wAAAx+tVbrR7mdCh1CQIccD/wDXW864PAP5Uwj3H50AcBrejX1u0f2u2TU4Cx2Sxg+ZH7EEg4+h/AVUHhaw1rUba6vbKe3kiG1Q65BA+pOPwr0h41cjdtJ9TURhGfl4HcDvQBUeF7SzSPR4LfcrACKTKKF7ncFOT7Y/Gr68qQyqD3OOaq3y3LwJHp0kMVwrZdpk3ps78BlwffOK4vX/AIjabZXH2XSy+tXgba66ehZEOe8h+X8iaAO9clTkMSO/SqdzBKy5tLny29CNw/z1rm9H+IOh6hcQ2zTzWl3IdpiuYzGQ393OMZ+hrtFh44CY/wB6gDl59O12WYk6hGPdIyueO55qIaJqYhKG7QISWIVnAJJyT9Sea67ycE4wCfTrSBG2nqfcigd3see31vqGmTwy38El9C4IEsI3PGR/eBI4OexqMaFY+JbtLi902SO4iBCyyrg4+uTXorxKeGUVGYljUBRx2oEUktnsjaQada2rWgBEpaQq8fptG0hs+5FXXL7T8uD9M1SvTdRsbqKe2t7K1QvctOhxj13bgFA+hzXA6h8Qprt3Xwxps+qxxnAumHkQue+0N8x79hzQB6NJnqVLH6UhTdkZZB/d44rhLHxxqcU8Emt6PLYWUjBDO4G1SeACw4HPrivQ4UikjDRSo6tyGUjBoAS1UmeMbznPXjNeA/tCpi70z5txWWVck5PUV9DQxKkyEdj6189ftCH/AE7TtoB3Sy4P444oAwBz0paRRtGBS0AFFFFABRRRQAUUUUAFFFFABVLVOIYTkgidMY+tXap6p/qIuP8AltH/ADoA+lfCMHm2E+1irBl6HjpVnxXoNvrFmkV00qPAxe3uYjiSEkYI9Cp4yD6VT8KXDW1vMpUFSVP/AI7Wjd63DG+yQPlugAJoA4a+n1/THCW9mLy3Xo0cwiH5MvB57ZrNPiPxTG37vQLfPdnuC38kru21iyjDHmPHYDr+VRHWbVxiOVsntkZ/I4NAGHpfi+8s4/M8Saa9vBjLXFpumSPgnDrgMOnXBHSr6+PvD+oxyjSFv9U25ysEBAODwSWxwcdefpVme7s2VSzkg9umPzqK2n0+zBkiaPD/AMSNkHH/AOugDnovDWta7G8esTxadZsOLC2LFD1wJXJ3Se4yB7V0um+HINOtUhMVsxUAZSMKn4DtUd1rBYyQWrNuZcCZPvKfbIIz9cirFndv5caNJJcyKMM5xuz74AH5UAWYtNtCXEltEyOCskZQFXGOhB6iuTnsNY8IJs0MNqejbsRWLuY54Bxna+NrLkk4OCPfrXWi6KglwB+NQvq1qQu54/mz1OR+lAHJzeNvEGRFbeGLtZfWW4QAfiM+9NHi/wAWbgG8NRrnu13/APY11Iv7ExGbKBF6nb07elNXULYMGEsOB0JXr9OKAKVl41gg2J4kgk0p2XKyylXgf2Eg4z7HBqyPFulXUFxLplxJfCIf6m1TezHsM9F/E/4Uk1zZOWEgVsnq2T/TmmWd5pdruWJ4I9/LAME3f40AYd5pOu+K/Lm16YWenbtw0tM+Uoz/AMtMEb2478DPArZtNF06xXybe0hK8Y38dOmBgVJe6jHdWhjtrlopEcNvgZWdh6fMCMfhn3q3HdqAodWYd2P/ANYUAJDoOn3dpLa31jFNZzrtliPQ9cEHsR1Brm7rUPEHgp5LZ7a61/ShgwXUGPPVc4CSJjkjPUGprvxcdG8QXNpqcZ+xShJIJYwCUBAByM9Mhj6+xBGOlk1O3aIOZYijAFWbBVgeRg1nCrGbaW6OzE4GthoQqVF7s0mn0en5rZrucefGviK7kTyPDN2Ac5LkKB+v1q4PEXiYjC6I0ZHTdOP/AImt59StI2zI8QU/xdv5VP8A2taRruaZQnrjj88VocZh6f40js3Ft4ot5tMuGGY3ch4pPYOOM8jg4NWrjxxojwSNY+dqbx8GG1X5iccfN0A6ZP6HpTr69sLooZAjlDkF4s5PtxVFLrSrFljRYod3Tau0MfoPwoAxp9D17xVeRTeI7lYtMjbzE0qEbYVPYsesjd8kdc44ruLbSoFUbEzj2IJrLe9R7yGWO4miijGGgULskPqxZSw69iOlXV1Jg42OCrdMf/XoA1BZ28kEttcwpJaTKUlibo6nt/8AXrzm/g8ReGWMehRyanpowI0eQRzoPQlgVIGeox9K7dtV8uEO6qq+pb+dQS6tZSEbmViOmB/+qgDi18WeM2fK6Fb274O1r253Kx9goya4b40tJPp/hmXUBGt3L5jziEkopLdFzzj617O+v6cAWDNFjqzRgY/OvGfjowl/sKSNso5dlOc4GaAMqiiigAooooAKKKKACiiigAooooAKp6r/AKiL/rtH/OrlVNTBMEWP+e0f86APcodSg09gJvO3sgKsi71Bx3HH6U+71eyv7Qj7dtkYdo2Uj6E7sVxvxIE8tzo4tA2BbtuwDgHjrgEfnXJSXV5bgRPfpCU/hMxXr7ZGKAPR/sdoxcyak7TYA3OrN37/ACg9M96lt9GdNzW93DKD1AjwPwORXANr7yw+XPqFuQRjKAMx/wDHjSJqVwBviZGJ53MjjP5E0Aeg3saQQSS3N9GmwZ4BD/8AfPJ/Os+3022vGF0JpWDD1ABFccNSvrhZBNO8QZcMQwAI6ck7at+HtTvLaGWBJo1DEEgYGcdM4OKAO/hs4UjaOW5k2MMEKQP1XkfhitKJrO2hCmZ2B7uzE5+vf868o1LVriaaXZclSeoJyCfYgjj2xWXfX91IWaO7zMTkvGSvb0BA/SgD3S3USjzYLhJFPoAR+p/nXPanpcrXk5guYoh8uY5Ru59A1eVDXdXiiAS6aV1ON0uGz9QQT+prSs/EetxjZ5Vo4P8Az0iNAHfLo8rQK32qKRl4UKAN34dKmXR7vyW23Uecg8qxYfTmuIj1/UVYbvsKeqiN8D8dxzV9PFFyg/eQWWBzkMUP6rigDpG0W7IWSa6XjPzEc/hnNOXw+piYzzySA9zjpXEXOuaxfsS+xI5ctFGwIJUZ4DEgH8K6vRNU1O+092Y2saLGd5ZHBQ/gOPoD+NAGn/Y6iJU89kQNuBGAfp2OParkGjAqUuJRtU9mIx+X+NcBeazqki+Ut4IwJN4aJgCcdsl8ke1Zs3iLVY5Nr6hd8dAf8Q1AHoPiLweNUkinjvdixIVaRwZGbkbR16ctz/kZulaI0EEkMcyrJG2HVwVyMnD8ev4+mflxXKf8JjqNrHskkBlH3hncR+O0j+dMbxZcyv5vnWgk27cBWG4dgen+fqc4eyjCbqpavc9RZhXxGHjgak/cXwrz13++2u2myud1b6BcFSzXAkPHLopA/HGRS3Hh27kK4uGlfPDocr/3ztNcvZeLdQSHYIIJAOpaQjP6GtEeMblgENnHHk/eWXB/9AI/Stzy2raM3JNEmW2Vpp5EkHXCj+ZApi+G4yRud2J6hGXjHt/9auLn1zWL0XCw+WYw3+qjXzPfhg2D/nitnw1rep3dhPNcG0jVVMaGffwx74A9/wD9VAG9BpEasryTTKB91d3B+oHWtCM2cCbTcyHZncEkYhfqBnFeVX+qa0hf7RqaozDaxPlogGeu0Nx7HrWWdSuJ2Ci/jcqMFoy7luO5JP6UAe3m6if5YNThbjONynFc1Lpj3Ers13FISRlmYEn07muDsNTugwEk5lVxgfvNu0+vLfzApst/qEQ2HUZJW6fMqP8ArzQB6HbaQyRSeber5bYADKT/ACOK4H41qlvZ+G4oyJNoc7h3+btVY6jqgjJLt8ozkxlf5EVb+LPz6J4KknQiR1cvxgn5vegDIooooAKKKKACiiigAooooAKKKKACqmonC2/OB58efzq3TJokmhaOQHkghh1Ug54oA9iv3tWtGS4nW3mkClDtJ4Ht/wDXrnLvTdNaLzrq/hkcnAyjDPQf55rgrg3Fzjz9Q1CUKMDzLgtj86jWJ0+7eXo+k2P6UAeh2ulaQZSq3NnLgf3Sac/hjTpyzobPJ4OI0XH6V54onVty39+GHQic09pLtgA2pakfrcGgD0fStAtNOx9ndWaIk7+GBz+p69xU/wDwi2lbGkkjgBkOd+wAg55rzOGa6hJMeo6iB6faDg/WnSXN65JOp6kM9QLlsUAd1Lpeg25/eyiJFIwIzt/kKX7H4alDSSXhMhHJklYsfTtXnzG4YYfUNQZfQ3Bp6y3igBdU1IADGBcmgDtn8PafJdPOoWdZMY8v7v1x94/WpU8NaVI2xYoFb33c1wsc97EwaLVNTRsYytyRSpc3yfd1bVF/3bphQB3jeFLCIACOEyKOiSMD+hzSzeE4Arh5HRuNqiV9p9eTXBtc3uzC6jqG7+8bg5qMyXjD59T1In/r4NAHpUWl2Nk8Uly6tn5AJnyCcDpnrW1pWnWS2zKVUxSHOzB5/mK8bMl2cZ1PUTj/AKeDU0d7qUYxHrOrIPRbthQB6wun6aLoPZ2cJuOgLQdPocVDcaNCsEgigs4h/Eog4OfXivJ5ZLqYATalqTgHPzXBPNSte6kUCjWdW2joDdtgUAdp/wAIwju6xW4OfvKC+Px+YCpLPw1bSyYYRx5H3cqMf99Mc1wq3WooPk1jVFb1F0wo+03hjw+pagW/v/aDmgDupPD1rb3McUzMsUvHmBgNjcAA4OOf89RSz+G7OIEpLuOPlxK5OfwUj9a4Lzr3cCdU1EgENg3BPI5H61JLd6g3TVtUA6gfamIFQvdduh0Taqw5/tLfz7P9H8nrdno9pp2m2FqgupFQM2xXaT5S3oN2Mk1oWGjWCWsqoFdX5IxgD6e1eRtJdu6vJqeos69GNwcj6VKl3qEePL1jVVx0xdsKs5z0y50rTrC3HkJb2xPVljCBx6FsHue1V9Og0xQVn1GMK2MyRTnKgdgMj+VeaTG6lKM+pagzKMAtcE4HtSKs4/5f7/PtORQB29xoltPIzRzQTxM5OHZcL1wRnP8AKruk6LbQufntLeQD5mj+Qn8eK88BuQMDUdQ/8CDUizXSjH269K+8xzQB6NqOiWQl/eSWMxbjc+GJx71xPxoHl2nhcREeSiOFEf3fvDpWdJJdSE51HUAD2FwcVXuoHvGt/tt1dXKQHMaTS7wvOeM9PwoAnooooAKKKKACiiigAorf/wCEK8Vf9C1rf/gBL/8AE0f8IV4q/wCha1v/AMAJf/iaAMCit/8A4QrxV/0LWt/+AEv/AMTR/wAIV4q/6FrW/wDwAl/+JoAwKK3/APhCvFX/AELWt/8AgBL/APE0f8IV4q/6FrW//ACX/wCJoAwKK3/+EK8Vf9C1rf8A4AS//E0f8IV4q/6FrW//AAAl/wDiaAMCit//AIQrxV/0LWt/+AEv/wATR/whXir/AKFrW/8AwAl/+JoAwKK3/wDhCvFX/Qta3/4AS/8AxNH/AAhXir/oWtb/APACX/4mgDAorf8A+EK8Vf8AQta3/wCAEv8A8TR/whXir/oWtb/8AJf/AImgDAorf/4QrxV/0LWt/wDgBL/8TR/whXir/oWtb/8AACX/AOJoAwKK3/8AhCvFX/Qta3/4AS//ABNH/CFeKv8AoWtb/wDACX/4mgDAorf/AOEK8Vf9C1rf/gBL/wDE0f8ACFeKv+ha1v8A8AJf/iaAMCu3+Clla6j8TdGtdQtoLq1k87fDPGHRsQyEZU8HkA/hWP8A8IV4q/6FrW//AAAl/wDiaP8AhCvFX/Qta3/4AS//ABNAHUeAfh7HqVzqkfiuPVNPmtIoZY7JIHS4mjeTY0qp5buyqAeAhBJGWUZNWIrbQNK+Fd/f21p/aE0munTWvmWMNNAELboxJG/k7kPb5g2GLEAJXH/8IV4q/wCha1v/AMAJf/iaP+EK8Vf9C1rf/gBL/wDE0Abnxss9Ps/H9yNGsktdPmggmhMIUQTK0Y/eRBVA2HpxnLBjnnA6SLwFpXh628I65rBzDNqdtb3kL3KS27rJGsgkEhjCeWDncB5ikZAkBBNef/8ACFeKv+ha1v8A8AJf/iaP+EK8Vf8AQta3/wCAEv8A8TQB3ni/wt4b0yz8Ta3qNhrEDxa/Jp1tY280cKbSgkDZMR2oQWK4B4KDnlqNO8GaTrXgvQZka6S8uNJ1K5t7eMQ+ZPdQOgCArEHkDfO2wlmAGAcAk8H/AMIV4q/6FrW//ACX/wCJo/4QrxV/0LWt/wDgBL/8TQB65F8IfDY12WwluNYZDqv9nRss8alV+wi53N+7O453Lxjgj058r8feH7XQLvSG0+SdrXU9Mt9RSOdgzw+YDlCwADYKnnaOvTjJr/8ACFeKv+ha1v8A8AJf/iaP+EK8Vf8AQta3/wCAEv8A8TQBgUVv/wDCFeKv+ha1v/wAl/8AiaP+EK8Vf9C1rf8A4AS//E0AYFFb/wDwhXir/oWtb/8AACX/AOJo/wCEK8Vf9C1rf/gBL/8AE0AYFFb/APwhXir/AKFrW/8AwAl/+Jo/4QrxV/0LWt/+AEv/AMTQBgUVv/8ACFeKv+ha1v8A8AJf/iaP+EK8Vf8AQta3/wCAEv8A8TQBgUVv/wDCFeKv+ha1v/wAl/8AiaP+EK8Vf9C1rf8A4AS//E0Af//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    M-mode echo in a patient with a bicuspid aortic valve. Note eccentricity of aortic valve and thickened leaflets.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f21_52_22351=[""].join("\n");
var outline_f21_52_22351=null;
